intivo works by stopping the virus from multiplying and infecting cells . incivo is used to treat hepatitis c infection in adults and adolescents ( 18 years of age and older ) who are already taking peginterferon alfa , ribavirin and telaprevir , medicines called ns3 - 4a protease inhibitors . the ns3 -- 4a enzyme is essential for hepatitis c virus to multiply and infect cells . in combination with peginerferonalfa and ribavir , incivo can be used : for adults and children ( 18 - years of old ) who have previously taken an interferon
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking peginterferon alfa or ribavirin . warnings and precautions talk to your doctor or pharmacist before taking incivo . if you take any of these medicines : - if you currently take any other medicine containing peginerferon avfa or / or ribvirin . if any of them apply to you , tell your doctor . warnings , precautions and precautions before taking the following medicines : 56 - if your doctor has prescribed the medicine alf
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen . the recommended dose regimen is 3 mg twice a day ( 6 mg twice daily ) taken in the morning and evening , followed by 2 mg twice weekly ( 8 mg twice every day ). your doctor may prescribe a higher or lower dose depending on the severity of both hepatitis c virus infection and human immunodeficiency virus infection . your dose will be calculated by your doctor using the following table : your doctor should prescribe the right dose for you . your child will be given
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you develop rash , an itchy skin rash or any of the other symptoms of the rash ( listed in section 6 ). other symptoms may be similar to those of a severe skin reaction . tell the doctor immediately about a skin rash . if your rash does not go away , or other symptoms are similar to a rash , you should contact your doctor . fever , tiredness , swelling of the face , swelling or lymph glands , a wide - spread rash with peeling skin , fever , flu - like symptoms , painful skin bl
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo contain 375 mg telaporir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinibryta contains the active substance daclizumab beta , a monoclonal antibody . what zinbaryta means and how it works zininbrysta is used to treat multiple sclerosis in adults . it is used as therapy for two ms treatment . it may be used in combination with other treatments to reduce inflammation and the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms , which can be characterised by repeated attacks ( rel
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from liver problems . warnings and precautions talk to your doctor or pharmacist before taking zinibryta . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell your doctor . if your doctor has told you that you are not suitable for taking any other medicines . if this applies to you ( or you are unsure ), tell your physician . herbal supplements tell your pharmacist if you
your doctor or nurse will give you zinbryta exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbaq is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . the recommended starting dose of the medicine is 40 mg once daily . your dose may be adjusted depending on the results of this blood test . your physician will ask your doctor to perform a blood sample before you start injecting yourself zinryta is injected under the skin ( subcut
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may effect up to 1 in 100 people ) severe inflammation of the liver may lead to death . tell your liver
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . before you start using a new syringe / pen , use a refrigerator to store it in the original package . zin bryta syringes / pens may be stored for up to 30 days in
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml solution for injection : each pre- filled pen contains 150mg of dlizumb beta . 1ml solution for infusion : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ) ( see section 2 ' zin bryta contain sodium '). what zinberryta looks like and contents of the pack zinbaryta is a clear to slightly yellow , colourless solution
what wilzin is wilzin belongs to a group of medicines called metabolism products . what wilson ' s disease is wilson is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect causes liver damage and neurological disorders . how wilzin works wilzin attaches to copper in the intestine and its further accumulation in the body . this results in wilson s disease . this treatment is intended for the treatment of patients with wilson .
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults with signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent , penicillamine . wilzin should be used during the initial treatment in combination with other anti - copper agents . penicilamine may be used if your symptoms do not improve after the treatment has been started . monitoring your blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : the usual dose is 25 mg / 50 mg once a day . this dose is 1 mg / day . wilzin 25 mg : once a daily dose is 2 mg / m2 . wilz 25 mg is once a morning dose is 3 mg / 1 day . your doctor will tell you how many capsules of wilzin to take . this will help you remember to take your dose . the usual starting dose is 50 mg / 2 mg once daily . wilzan
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ): very common : may affect more than1 in 10 people wilzin intake may cause gastric irritation during or after treatment . changes in blood tests , including an
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each 50 mg hard capsule delivers 50 mg of the active substances ( equivalent of 167 . 84 mg of oz zinc acetates dihydrated ). the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong , printed with " wilzin 50 mg
biktarvy contains the active substance bictegravir . it is an antiretroviral medicine known as an integrase strand transfer inhibitor . it contains the following active substances : emtricitabine , an antirutroviral medication known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiviral medicine called a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrel
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these : - any of your other medicines : - rifampicin ( used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ) ( a herbal remedy used to help prevent depression and anxiety ) warnings and precautions talk to your doctor before taking biktorvy if any of you : have liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may also prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your daily dose should be taken in combination with aluminium and magnesium hydroxide mineral supplements . your diet should be carefully checked by your dietician . your body may also need to take vitamins ( magnesium and iron ) to help control your acid reflow ( see section 2 " taking these medicines ").
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any of the following side effects you should stop taking biktarvy and tell your doctor immediately : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms may be due to an improvement in the body ' s immune response , enabling the body to fight infections that have no obvious symptoms . autoimmune disorders ( when the immune system attacks healthy body tissue ) are a common complication of medicines used to treat h
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir sodium equivalent to 50 mg bic tegravira , 200 mg emtritabine , tenofovel ( fumarate equivalent to 25 mg tenofoviir alufenamide ). the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , talc ,
novarorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your blood blood sugar may be increased when you start taking novonor on its own or in combination with metformin . if you have diabetes , no
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonere ( listed in section 6 ). if you have type 1 diabetes . your doctor will check the acid level in your blood regularly . if you suffer from diabetic ketoacidosis ( see section 4 ). if your doctor has told you that you have a severe liver disease . if your dose of gemfibrozil ( a medicine used to lower increased fat levels in the blood ) is 47 too low . if any of these apply to you , tell your doctor . if the doctor has advised you that the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . try to take noonalorm at the same time each day . you may take it with or just after food . the usual starting dose is 30 mg once daily . your doctor may increase your dose to 4 mg once every 30 minutes , depending on how you respond to the medicine . your daily dose may be increased to 16 mg once each day
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect . hypoemia may affect up to 1 in 10 people . you can see a hypo in section 2 under " warnings and precautions ". hypoglycasemic reactions are generally mild / moderate . however , hypoglycanemic unconsciousness may lead to coma . allergy allergy is rare ( may affect 1 in every 10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( anaphylactic reaction ). other side effects include : common ( may effect
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ). 1 mg tablet contains iron oxide red ( e 172 ) and 2 mg tablet . what novonm looks like and contents of the pack novonere tablets are white to off - white , round , embossed with " pfizer "
pumarix is a vaccine for use in adults aged 18 years and older to prevent pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . pandemic fluid is similar to ordinary flu but may be more serious . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are
you should not receive pumarix : if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients that may be present in trace amounts as follows : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you notice any of these , stop the vaccine and seek medical treatment immediately . an allergic response to any ingredients of pumarip is not recommended . this vaccine should be administered 33 once
pumarix is for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 to those of the same age ( 18 years ) as the other two active ingredients . pumix is a vaccine for use by children and adolescents aged 3 - 9 years . pumanix is also for use for children and infants aged 10 - 17 years . how pumarux is given pumarous is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and need emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection was given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where the site of thejection was given
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the vaccine in the original package in order to protect from light . after preparation of the vaccine , the vaccine should be used within 24 hours . do away with the vial and discard any unused suspension after 30 . do this to protect the environment .
what pumarix contains the active substance is split influenza virus ( 5 / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredients are haemagglutinin , which are used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - α - tocopherol , polysorbate 80 and adjuvants . the ingredients in the vaccine are sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate , water for injections . what pumarax looks like
what somakit t is somakiton t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . what somakt t is used for somakits t is only used to deliver a dose of gallium (" 68ga ") edotreaotide to your body . this procedure will involve administering the dose of either gallium or edotREotide directly into a vein or body areas . what it is used to do somakitas t is for a medical imaging procedure called positron emission tomography ( pemph
do not take somakit t - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking somakt t if you have had allergic reaction to any ingredient ( listed under section 4 ) of somaknit t . - if your doctor has kidney or liver problems . - in patients with renal or hepatic disease . children and adolescents do not give this medicine to children and adolescent below 18 years of age because of the risk of dehydration . the examination will be repeated every 28 days . - there are others
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be used in special controlled areas . 29 the nuclear medicine doctor supervising the procedure will decide on the quantity of somakttoc to be used . the usual dose of somackittoc is 100 mg or 200 mg megabecquerel per kg body weight . the nuclear nuclear medicine physician supervising somakiton t will perform the procedure for radiolabelling , somakitas t will be given by intravenous injection ( a single injection ). the doctor will decide upon the quantity and time of
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) which have been reported after administration of somakit to patients with symptoms such as warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . these effects may be due to ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only : radiolabelling will be done by means of technology . somakit t will be stored at a temperature below 4 ºc and protected from light . from a microbiological point of view , the product should be used immediately . do not freeze . do away with somakIT t if it is accidentally frozen . it must be stored below 4 ˚c and
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg of edotreaotide . - the other ingredients are 10 - phenanthroline , gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . the solution contains hydrochloric acid . what somakt t looks like and contents of the pack somaknit t is presented as a kit for radiopharmaceutical preparation . it is supplied in a glass vial with black flip - off cap . it
afinitor is an anticancer medicine that contains the active substance everolimus . everolim slows down the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women , when non - steroidal aromatase inhibitors ( such as non - steroids ) have failed to control their growth or spread . afinavitor is used in combination with a medicine called exemestane ( a steroid osteromatases inhibitor ) when hormonal anticancer therapy is not suitable . it is also used in adult patients with advanced tumours called neuroendocrine tum
do not take afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before taking afincer : if you : are allergic to everolimus , sirolimus , temsirolimuses or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings , precautions and precautions you should tell your doctor before taking the first dose of afiner : if any problems with your liver . if you have any disease affecting your liver , your doctor may prescribe a different dose of infinitor .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 10 mg of afinitor once daily . if you have liver problems , your doctor may prescribe a lower dose of afginitor ( 5 mg ) once daily , or a higher dose of 5 mg or 7 . 5 mg once daily depending on certain side effects . your doctor will tell you how long you should continue taking afincer . your dose may be adjusted by your doctor depending on how you respond to treatment . if necessary , your dose of the medicine may be
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps . the following side effects have been reported with afincer : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation of the lung ( pneumonitis 46 common ( might
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do open the blister to take the tablets out of reach of light . do this once a day . donot use this product if you notice any visible sign of tampering . do so , unless your doctor has told you otherwise . do your normal shopping and follow these measures to protect the environment .
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet : each film - coated tablet contains 5 mg of Everolimus in each film- coated tablet . afincitor 10 mg tablet ): each film film - coating contains 10 mg of of everlimus in one film - coat . the other ingredients are butylhydroxytoluene , magnesium stearate , lactose monohydrate , hypromellose , crospovidone and lactose anhydrous . what
what laventair ellipta is the active substance of lavent air ellipta ( umeclidinium bromide and vilanterol ) belongs to a group of medicines called bronchodilators . what laventAir ellipta looks like and contents of the pack laventairy ellipta comes as a clear , colourless inhalation . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that occur regularly . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . warnings and precaution talk to the doctor or nurse before using lavent air ellipta if you : have asthma , have heart problems , have high blood pressure , have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ), have epilepsy , thyroid gland problems ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day . check your doctor regularly while you are using lavent air ellipta . if you have symptoms of laventAir ellipta such as a sudden attack of breathlessness or wheezing , you should seek medical advice immediately . if this attack does not go away , you may use a quick - acting reliever inhaler ( such as
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , have difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ). immediate breathing difficulties immediate breathing problems
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umeklidinia and 65 microgramms umelidinIUM bromides . - the other ingredients are 22 microgramgrams vilancerol and trifenatate . - each inhalation powder contains lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ') and magnesium stearate . what laventAir ellipta looks like and contents of the pack laventAIR ellipt
the active substance of tremfya is guselkumab , a monoclonal antibody . this medicine attaches to a protein called il - 23 , which is found on the surface of nails . this protein is present in the treatment of psoriasis in adults with moderate to severe " plaque psorism ". plaque psoreiasis is an inflammatory condition that affects the skin and nails . tremfia works to improve the condition on the skin , and to reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and risks talk to you doctor or nurse before using or using tremfaya if : you have ever had an infection or an infection with tuberculosis . tuberculosis is a serious , sometimes life - threatening condition that can affect up to 36 people . you have signs of an infection , including symptoms
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . tremfya 100 mg is given as a single injection ( 1 pre - filled syringe ) under the skin ( subcutaneous injection ). you may be given tremfia for 4 weeks or 8 weeks after your last injection . if you have any further questions on the use of tremfYA , ask your doctor , pharmacist or nurse . if possible , ask you doctor , nurse or pharmaceutist . if not , you can give tremfiya to your child at any time during treatment .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : signs of serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not give this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre pre -filled syringe and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is clear and colourless . tremfia is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 vial of single - set pre -
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adults . persistent or recurrent ctph is characterised by surgical treatment , poor exercise capacity and symptoms of the disease . chronic throbembolicmonary hypertension ( pth ) is caused by a condition in which blood pressure is too high ,
do not use trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if the patient has a heart problem . - have had a heart attack ( myocardial infarction ) in the last six months . - suffer from
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) in the abdomen or thigh . trepanmix is supplied in a pouch containing a spare pump containing your treprostinil . the pump is inserted into the infusion line to reduce the risk of accidental overdose . the recommended dose is 1 mg , 2 . 5 mg , 5 mg or 10 mg per infusion . the infusion rate will be adjusted depending on your condition
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the infusion site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in 100 people ): dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ), joint pain ( arthralgia ), swelling of feet , ankles , legs , fluid retention , hot flush pain in arms and / or legs 36 uncommon ( may effect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp expiry period refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with trepulmix vial . store it in the original package in order to protect from light . trepulemix may be used for up to 30 days as continuous subcutaneous infusion in a single vial or for up - to - date periods in a hospital or clinic . if you use more tre
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treprostail ( as sodium salt ). each 10 ml vial of 10 ml solution contains 10 mg trepristinila ( as water for injections ). each 20 ml vials of 10ml solution contains 50 mg trestinill ( as hydrochloric acid ) and sodium salt . trepiulmix 5 mg : every 5 ml vinal contains 5 mg trepistinIL ( as saline salt ). every 10 ml ampoule of 50 ml solution includes 50
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). thorinanes is used to : 1 prevent existing blood clots from forming . 2 prevent stopping blood cl clots forming in your blood . thorinne is used in adults to : reduce the risk of blood clumps forming in the blood . reduce the time it takes for blood clinches to form in yourblood . before an operation if you have an acute illness called unstable angina . reduce your time on dialysis if you suffer from blood clops in the past . reduce or stop
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have had a reaction to heparrin , such as a severe drop
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . the bleeding should be under control . if you experience any bleeding event that does not stop by itself ( exceptional weakness , tiredness , paleness , dizziness , headache , unexplained swelling ), stop taking your medicine and contact your doctor immediately . if any of the above apply to you , tell your doctor or nurse immediately . your doctor may decide to change your medicine or stop it temporarily . if your doctor thinks that you may have a severe allergic reaction , including difficulty breathing , swelling of the lips , mouth , throat or eyes , or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . one ml contains 100 mg of enoxeparin sodium ( as monotherapy ). each pre - filled syringe contains 0 . 2 ml of enxaparin . after dilution , one ml of solution contains 2 , 000 mg of the active substances enoxafarin sodium and / or water for injections . one pre - fill syringe of 0 . 02 ml contains 10 pre -filled syringes .
sensend contains two active substances : lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , allowing the flow of semen into the semen and thereby preventing ejaculation .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have allergy or sensitivity to local anaesthetics , ask your doctor for advice . if you have been treated with amide - type local anahetics . if your doctor has told you that you have a genetic disease or other condition that affects your red blood cells ( glucose , phosphate deficiency ), anaemia ( methaemoglobinaemia ). if any of these apply to you , tell your doctor before using senstent . warnings and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one spray of senstend 3 times a day . the recommended starting dose is 3 sprays ( 1 spray ) in the head of your penis each day for 3 days , followed by 24 sprays in the morning and evening . the dose may be increased or decreased by up to 4 sprays per day depending on your response to the spray container . the pump mechanism is to allow the valve to relax and to avoid contact with eyes , nose , mouth and ears .
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to1 in 100 people ) headache local irritation of the throat , irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the penis pain or discomfort in the pris itching in the centre of the penile with a high temperature . other side effects include : common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer after this period . puncture the container before use . donot burn . do this if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilucaine . 50 ml solution contains 7 . 5 mg lidOCaine and 2 . 5mg prilacaine . - each spray container contains 6 . 5 ml of water for injections . 20 ml solution for injections is supplied as a single dose . each spraycontainer contains 5 ml or 12 ml of light yellow cutaneous spray . what senstends looks like and contents of the pack senstent is an aluminium spray container with metering valve . each pack
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melanoma can be treated with complete resesection in adults ( treatment including surgery or adjuvant therapy ) advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma if previous therapies have not worked or have not been able to work , including an autologous stem - cell transplant ( a transplant ) advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) opdivo contains the active substance n
do not use opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using opdivor if you : - have problems with your heart , such as a change in the rhythm or a change of the heartbeat . - have an abnormal heart rhythm . - develop problems with the airways , such that your lungs get narrower , breathing difficulties or cough . - inflammation of the lungs ( pneumonitis or interstitial lung disease ). - have diarrhoea , watery , loose or soft stools . - notice
opdivo is available in two strengths : opdivo 240 mg in 2 strengths : 480 mg in 4 strengths opdivor in combination with ipilimumab is used for the treatment of skin cancer . opdivos in combination 1 mg of nivolumab per kilogram of your body weight . the recommended dose is 4 tablets of opdivol plus 240 mg ( 2 tablets of nvelolumib per kil kilogram ) of your weight . each 4 tablet of opDivo contains 240 mg , 2 tablets ( 480 mg ) per kiloreg body weight and each 4 course of opiono with
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store below 25 and transport refrigerated ( 2 - 8 ). do not freeze . after dilution , chemical and physical in - use stability has been demonstrated for 48 hours at 2 - 10 . from a microbiological point of view , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of niviolumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg nivlumab and 240 mg of 24 mg of 25 mg of 30 mg of 50 mg of the 25 mg /ml . - the other ingredients are : sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelTad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events (
do not take clopidogrel tad : 30 if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you, or if any part of your family is affected , consult your doctor before taking clopridogrel tart . warnings and precautions take special care with clopIDogrelTad : if you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl tad ( 4 tablets of 75 mg ) once at the start of treatment . then
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopIDogrel tetad looks like and contents
tacforius contains the active substance tacrolimus . tacforius is an immunosuppressant . after your organ transplant ( liver or kidney ), your body ' s immune system will try to reject the new organ . tacfortius is used to prevent rejection of transplanted organs by the liver or kidneys , and to reduce the effects of any previous treatment you were taking at the time of your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been given sirolimus , or any macrolide - like antibiotic ( e . g . erythromycin , clarithromycin or josamycin ). tacrolamus immediate release capsules ( e. g . tacnier ) are available in two strengths : tacforia prolonged - release capsules and tacrosimus prolonged -release capsules . tacforian prolonged
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . patients who are already taking the same tacrolimus medicine but have had a transplant will receive a different tacroleus medicine . always take this medication exactly as described in this leaflet . check each time you take tacforius to make sure that you have taken the right medicine . the rejection of your transplanted organ will be caused by your body weight . the usual starting dose for transplantation is 0 . 10
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must look out for infections while you are being treated with tacforius . severe effects of allergic and anaphylactic reactions ( benign and malignant tumours ) have been reported during tacforia treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ) and agranulocytosis ( a severely lowered number of white blood cells ) have also been reported . haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febri
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . discard 1 capsule after opening the aluminium wrapping . do away with the opened capsule . do throw away any unused capsules via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg : each prolonged - release hard capsule contains 0 . 25 mg of tacrolamus ( as monohydrate ). tacforias 1 mg : one capsule contains 1 mg of ticrolimas ( asohydrate ). each prolonged release hard capsules contains 3 mg of of tacrulimus (as monohydrate ) . tacfius 5 mg ): one prolonged -release hard capsule contain 5 mg ofTicrolamas (asohydrate ). the other ingredients are capsule content hypromellose 2910 , ethylcellul
clopidogrel zentiva contains clopidogen and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelzentiva is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events ( such
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelzentiva . warnings and precautions the following are reasons why clopidineogrel ventiva may increase the risk of bleeding : if your doctor has told you that you
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . clopidogrel zentiva may be used in aluminium blisters if the outer carton is damaged or shows signs of deterioration . do this in accordance with local requirements . donot throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopidoogrel ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clopiderel zenta contains lactose ' and ' clopsidogl zentva contains hydrogenated castor oil '): tablet core : mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose (
yttriga is a radioactive medicine that must not be used after the expiry date which is stated on the label after exp . the expiratory date refers to the last day of that month . yttrigba is stored in a refrigerator ( 2 - 8 ). it is stored at room temperature ( up to 25 ). it must not freeze . it must be used immediately after reconstitution . if yttiga is used in combination with another medicine , it must only be used in tiny radiation doses . the treatment should be supervised by a doctor experienced in the use of radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you are pregnant or think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yttrida - yttrada is a radioactive medicine . it is not to be used in combination with another medicinal product . radiopharmaceuticals are sensitive to the effects of ytriga on radioactive material . radioactive medicinal products are stored at 2 to 16 in the outer carton . other medicines and yttarga tell your nuclear medicines doctor if you
the treatment will be initiated under the supervision of a doctor experienced in the diagnosis and treatment of medicinal products . method of administration yttriga is for radiolabelling of medicinal product for specific diseases . yttiga should be administered immediately after preparation . if you are given more yttrada than you should in the event of overdose , your doctor will provide appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage will be in accordance with local regulations . radioactive substances are disposed of in accordancewith local requirements . any unused product or waste material should be disposed of appropriately .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttrada looks like and contents of the pack yttrida is a clear , colourless type i glass vial with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , in patients who have not received prior chemotherapy . cimbra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . how ciamBra works lung cancer usually responds to treatment when your disease has responded to treatment with initial chemotherapy . however , ciamra may be used as a treatment for patients with moderate stage of advanced
do not use ciambra if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamBra ( listed in section 6 ). if you plan to stop breast - feeding during treatment with ciamba , tell your doctor . if you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor before using ciamra if you or your family have or have had problems with your kidneys . before each infusion , your doctor will check your blood , kidney and liver function to make sure that you have enough blood cells and that you are receiving c
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . your doctor will work out your dose based on this body surface area and will adjust your dose and duration of treatment depending on your blood cell counts . your healthcare professional has mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamBra will be given by infusion into one of your veins . the infusion will last approximately 10 minutes . cimbra will be
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38ºc or greater sweating ( common ). infection may occur if you have less white blood cells than normal which is very common . infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ), with a fast heart rate ( uncommon ). if you are having pain , redness , swelling or sores in your mouth ( uncommon ) allergic reaction ( common ): if you develop skin rash ( common , may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store below 25 . do use the reconstituted solution immediately after preparation . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 9 , 8 , 15 or 25 . the reconconstituted product should be used
what ciambra contains the active substance is pemetrexed . each vial of ciamra 100 mg contains 100 mg of pemetreed ( as pemetreoned disodium hemipentahydrate ). each vials of cimbra 500 mg contains 500 mg of the active ingredient pemetereed (as pemetretrexed dis sodium hemipontahydrates ). after reconstitution , the solution contains 25 mg / ml of pemphigus . further dilution by a healthcare provider is required . the other ingredients are mannitol ( e421 ), hydrochloric acid
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ). immunogam can help to control certain infections in your blood . immunogaman can be used in adults with increased levels of human hepatitis b immunoglubulins and immunoglobinulin g ( igg ) in the blood plasma of screened patients . immunoam is used to treat adults who have not been vaccinated against hepatitis b virus . immunogenam is given to protect against hepatitis c virus in haemodialysed patients who have had vaccination before . immunoglogam works by interfering with the action of a hepatitis
immunogam should not be given if you have an allergic reaction to human immunoglobulins or other blood products . if you suffer from an iga deficiency , an allergic response to iga containing products should be avoided . children and adolescents immunogam is not recommended for use in children and teenagers under 18 years of age . immunogloglobulin can cause adverse reactions such as chills , headache , fever and vomiting . allergic reactions to nausea ( arthralgia ) can cause joint pain and low blood pressure . moderate low back pain can be life threatening . antibodies to hepatitis b immunoglubulin regularly
munogam will be given to you by a doctor or nurse who is experienced in the care of vaccination against hepatitis b virus . the first vaccine dose will be administered in combination with human hepatitis b immunoglobulin ( for administration prevention ). the recommended dose for hepatitis b in individuals who are immunoglodialysis recipients is 500 micrograms given every 24 hours for 72 weeks . the recommended recommended dose of hepatitis bin haemodialysed patients is 500 international units ( iu ) given every 2 weeks . seroconversion is the first step in vaccination of hepatitis c . immunogam is prepared by using a
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ): undesirable effects have occurred during clinical trials with immunogamer in the muscle . very common : may affect more than1 in 10 people common : might affect
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . donot use immunoam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . one ml of immunogaman contains 1 to 5 mg of human plasma protein ( equivalent to 96 mg / ml ). - the other ingredients are polysorbate 80 . what immunogams looks like and contents of the pack immunogamer is a solution for injection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunoglubulin .
remicade contains the active substance infliximab . inflixumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' tnfs ' and is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis remicades is used in adults , adolescents and children aged 6 years and older with crohn ' s
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) to any of these ingredients if you have tuberculosis ( tb ) if your doctor thinks you may have another serious infection , such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if you take reminade more often than you should if you accidentally take too many remicad tablets , contact your doctor or hospital immediately . if any of this applies to you , tell your
the recommended dose for adults with rheumatoid arthritis is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases is 5 mg for each kg of person body weight , given once a week . how remicade is given remicine is given as an infusion ( drip ) over 2 hours into one of your veins ( usually in your arm ). the third treatment will be given once every week . if you are given more remicADE than you should
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects . your doctor may decide to stop treatment or stop your treatment with remicade . tell your doctor straight away if you experience any of the following : signs of an allergic reaction : swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild to severe and usually disappear within a few days . an allergic response is usually mild and
remicade will be stored by the health professionals at the hospital or clinic . keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . remicade may be stored for infusion for up to 3 days at 2 to 8 , or for up or down 28 days at room temperature ( up to 25 ). do away with remicades if you notice it is not clear what the
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixumab . after preparation each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicada looks like and contents of the pack remicad is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white and the solvent is clear . remicades is supplied in packs containing 1 , 2 , 3 , 4 , or 5 v
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson's disease ). in parkinson ', s disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body involved in movement control . rasagilinea mylan increases the amount of dopamine produced by the brain and so improves movement control in adults and adolescents . raspagilrine mylan works by increasing the amount and timing of the release of dopamine from the brain into the body .
do not take rasagiline mylan - if you are allergic to rasaggiline or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan contains monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease . it may be used in combination with medicinal or natural products ( e . g . st . john ' s wort ) or pethidine , a strong pain killer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day . take the tablet by mouth once a morning . take rasagiline mylan at about the same time each day . if you take more rasgiline melan than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , show the rasvagiline milan carton . if someone else accidentally takes your tablets , show them the pack . if a child swallows some tablets , tell your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects of rasagiline mylan are similar to those of placebo . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 1 users in 1 , 000 ) very rare ( affects less than 1 usersin 10 , 000 ): very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain (
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasageiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggiline milan looks like and contents of the pack rasvagiline tablets are 11 . 5 mm x 6 mm , biconvex tablets debossed with " r " on one side and " 1 " on the other side
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , including tuberculosis . symptoms of infections may include fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . - tell your doctor if the patient has a serious heart condition . warnings and precautions allergic reaction allergic reactions may occur with symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . these reactions are usually mild to moderate and usually disappear within a few days .
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in adults and children from 2 to 17 years of age weighing 10 kg or more : one 30 mg tablet of hulio 20 mg is available . in children from 1 to 17 months of age , one 30mg tablet of tulio 40 mg is also available . enthesitis - related arthritis in children 6 to 17 year of age weighs 15 kg or less : one 20 mg tabletof hullio 20 mg will be available in the following pack sizes
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate and may not require urgent medical treatment . tell your doctor immediately if you notice any of the following serious side effects ( which may occur up to 4 months after the last hulio injection ): allergic reaction , including heart failure severe rash or hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired , coughing
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hul io 40 mg is a sterile solution for injection containing 40 mg of adalimimumab in 0 . 8 ml solution . the solution is clear to slightly opalescent and has a rubber stopper . hullio is available in packs containing 1 , 2 , 1 sterile injection syringe , 1 syringe needle
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox may be used to treat eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed you a low dose of any of these substances . - if the doctor has told you that you have asthma or skin allergy ( intense inflammation in your nose ). - the doctor may prescribe you other nsaids such as acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac . this medicine should not be used in combination with topical steroids such as cortisone . - unwanted side effects - bleeding
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye ( s ) twice a day . if you use more yellox than you should if you accidentally use too much of the drops , contact your doctor immediately . the next day may be the day of your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle with your thumb and fingers . tilt your head back .
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuuveo may affect your breathing during treatment . you have recently had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is only for single use only . you should swallow the tablet whole with a drink of water . you can take this medication with or without food . dzuveo must be taken with strong painkillers such as sufentanil . the recommended dose is 30 mg once a day . take the sublingual tablet with the disposable single -dose applicator provided in the pack . the applicator should be inserted into the tongue so that the tablets dissolve and can be taken
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , especially slow and shallow breathing . if you get any of these side effects you must stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) are inability or difficulty sleeping , feeling anxious or confused , dizziness , headache
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use this product if you notice any visible signs of deterioration . do ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of suffentenil . - the other ingredients are citrate , mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine , stearic acid , magnesium stearate . what dzuvello looks like and contents of the pack dzu veo is a white to off - white , round oval tablet with " d " debossed on one side and " 3 " debottled on the other side . it is supplied
erveleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body or cannot be removed by surgical treatments . it also helps to prevent sensitive prostate cancer from spreading to other areas of the human body where surgical treatment has not worked . it reduces the levels of testosterone in the blood . when resistant prostate cancer is treated with erleada , the levels androgens in the body increase . when androgens are removed from prostate cancer cells , the level of erleade decreases .
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if pregnant or think you may be pregnant ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine may cause seizures . tell your doctor if you take any medicines that may increase the risk of blood clots ( e . g . warfarin or acenocoumarol ). tell your dentist if you have any heart or blood vessel conditions . tell the doctor if any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . taking this medicine by mouth the recommended daily dose is one tablet of erleade once a morning . your dose may be increased or decreased depending on your response to other medicines . taking erlea with food and drink you should take erlead at the same time each day . if you take more erleado than you should if you accidentally take
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis ( see section 2 ). serious side effects tell your doctor straight away if you notice any of these serious side side effects . fits ( seizure )
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalectamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine cellulosa . - in the film - coating are iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what erleADA looks like
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for scan - related procedures , including a pet scan . it may be used : - if you have previously had treatment for prostate cancer or - if other tests have shown prostate specific antigen ( psa ) to be present at high levels . - if the cancer has spread . - an axumin pet scan may show that the cancer is getting worse . the scan will be recorded on the patient ' s patient alert card . your doctor or nurse will record the results of this procedure on the radiophragm .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . - axumin is given once a day for the duration of the axumin scan . this is 4 weeks . - during the scan , you will be given your usual medicines to take for the latest 60 minutes . - after the axum injection , urination will be interrupted . - the scan
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . the quantity to be administered depends on the type of radioactivity being detected . axum will be administered to you in a hospital or clinic
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( affects more than 1 user in 100 ) the effects of the medicine were mild . the following other side effects have been reported with axumin : uncommon ( affects 1 to 100 users in 1 , 000 ) pain , rash , altered taste in the mouth and altered sense of smell . the safety of this radiopharmaceutical has been studied for ionising radiation associated with cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor or pharm
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use axumin after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( as mesilate ). each 16000 mg dose of axumin 3200 mg contains 3200mg of fluiclovin ( as Mesilate . each 3200 - 32000 mg tablet contains 32000mg of the active ingredient ). - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin is sodium "). what axumin looks like and contents of the pack white to off -
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . these help to reduce pressure within the eye . azopt eye drops are used to treat high pressure in the eye in adults , adolescents and children with an illness called glaucoma . the pressure in your eye increases , which can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor or pharmacist before taking azopt . the same allergy may apply to some people . if you develop too much acidity in your blood ( hyperchloraemic acidosis ) while taking azop , tell your doctor . if any of these apply to you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes . the recommended dose is 1 drop in the affected eye each day . if you have the eyes that are affected , azopt can be used in two different ways : 1 drop into the affected eyes each day , for 1 week , 2 weeks , 3 weeks . how to use the azopt bottle : wash your hands . remove the cap from the bottle . the cap can be removed with a snap collar . hold the bottle with your thumb or finger , pointing down towards your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects include : bad taste . uncommon side effects - effects ( might affect upto 1 in 100 people ) − effects in your eye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid itching , red
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzaolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide to maintain acidity levels ( ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack containing
the active substance of forxiga , dapagliflozin , belongs to a group of medicines called medicines taken by mouth . it is used to treat diabetes by controlling the level of sugar in your blood . it has been shown to lower the level in your urine by about 18 % . forxigo is used in adults to treat two types of diabetes : type 1 diabetes , where the body does not make enough insulin . for xiga is used for the type 1 type in which the body either does not produce enough insulin or cannot effectively use the insulin it produces . diabetes occurs in people who are overweight or obese . type
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you , tell your doctor straight away . - if your doctor notices any of your following : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is one tablet a day . your doctor may increase your dose to 10 tablets a day ( 5 mg ) if you have a liver problem . your dose of both forxige and forxigo for type 1 diabetes is two tablets a morning , one tablet in the evening and one tablet at bedtime . your daily dose should not exceed 5 mg . taking this medicine swallow the tablet whole with some water . you can take forxinge with or without
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( seen very rarely , may affect up to 1 in 10 , 000 people ). angioingema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( seen commonly , may affects up to1 in 10 people ) is a rare but serious complication of type 2 diabetes . it may affect between 1 in 1 , 000 and 1 in 1000 people . diabeticketoacidemia ( seen rarely , might affect up in 1 in
what forxiga contains - the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapapagllozin propanediol monohydrate equivalent to 5 mg dapablifloin . - the other ingredients are : tablet core : microcrystalline cellulose , lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350 , yellow iron oxide (
mifamurtide is a medicine that suppresses the growth of certain bacteria in the body . it works by interfering with the immune system ( the body ' s natural defences ). mepact is used to treat osteosarcoma ( bone cancer ) in adults and children aged between 2 and 30 years . it is used when surgery is not possible to remove the tumour and chemotherapy is not able to stop cancer cells from growing . it reduces the amount of cancer that can be passed on to your child and keeps it at a low level . it also helps to shrink the size of the tummy .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids can affect your heart or blood vessels , which may result in blood clots ( thrombosis ), bleeding ( haemorrhage ), inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor . some of the effects of
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of mepACT is 2 mg mifamurtide once a day . this will be taken once a week for 12 weeks . your doctor will decide how many treatments you need . your dose may be adjusted by your doctor , depending on your chemotherapy schedule . your chemotherapy will be repeated every 36 weeks . how to prepare treatment mepat is prepared by a special process called " infusion ". the
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients receiving mepacting ( transient ) paracetamol . if you experience fever during treatment with mepACT , you should contact your doctor immediately . stomach problems ( nausea and vomiting ) and loss of appetite have been seen in patients who received chemotherapy . tell your doctor or nurse immediately if you have continuing fever and chills . these may be signs of a serious or life - threatening infection . in children and adolescents , the use of mepacts in children is not recommended . if an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in outer carton in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 25 ) for up to 6 hours . do this medicine if you notice any visible sign of deterioration . do
what mepact contains the active substance is mifamurtide . one vial contains 4 mg of mifamanurtide ( as besilate ). after reconstitution and suspension , each ml contains 0 . 08 mg mifmurtide per ml . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' mepacts contains lactose '), 2 - dileoyls - sn -glycero- 3 - phosphate - l - serum monosodium salt ( see also section
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and the face to reduce redness ( rosacea ) and redness of the face . rosica is caused by high levels of blood flow in the facial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels which help to prevent the excess blood flow and red skin from forming .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). if you take the medicine under the skin ( for example , if you have taken certain medicines for depression or parkinson ' s disease called monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , moclobemide ), tricyclic antidepressants ( e. g . imipramine ), tetracyclic medications ( e e .g . maprotiline ), mianserin and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin ( usually on the face ). this medicine is applied on the surface of your body . it should only be used on body surfaces , such as your eyes , mouth , nose or vagina . if you have any further questions on the use of mirvasoa , ask your doctor , pharmacist or nurse . how much mirvasoe mirvasos is applied twice daily on the same face . the treatment is usually started with a small amount of gel ( a pea -
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain , discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( worsening of rosacea ) the treatment should be stopped immediately and symptoms should be observed ( see section 2 " warnings and precautions "). contact allergy : allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are given mirvaso stop using mirvasoa
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with the tube and bump . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasos contains methylparhydroxy benzoate "), propylene Glycol . what mirvasoa looks like and contents of the pack mirvasop
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body against infection and cancer . bevacsizumb binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found in the lymph vessels of the body . the vegef protein is found on blood vessels where it stimulates their growth and allows blood vessels to receive more oxygen . be vacizumsab
do not use this medicine if any of the following apply to you . do not use mvasi : if you are allergic ( hypersensitive ) to bevacizumab or any of those other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic or hypersensitive ), to chinese hamster ovary ( cho ) cell products if you have been pregnant . warnings and precautions talk to your doctor before using mvasis . mvasic may increase the risk of developing holes in the gut wall ( inflammation inside the abdomen ), diverticulitis ( stomach ulcers ), colitis
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual starting dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . your doctor may increase your dose to 15 mg per kilogram of your bodyweight . your dose of the mvasis will be calculated by your doctor . you will be treated with mvasic every 2 or 3 weeks . the number of infusions you receive will depend on how you respond to treatment . your physician will calculate the correct dose of this medicine for you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : side effects that may occur during treatment with mvai or after chemotherapy . tell your doctor straight away if you notice any of these side effects . stop using mvasis and tell your healthcare professional straight away allergic reactions . signs of an allergic reaction may include difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side effects include : severe side effects ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 unless dilution has taken place
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumumab in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active substances bevACizumb in 1. 4 ml of water . each 16 ml vials contains 400 mg of of beviacizumaab in 16 .5 ml of solvent . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in adults , adolescents and children who are not able to take other medicines . it works by inhibiting the growth of refractory mantle cell lipoma ( b - lymphocytes ) in your own white blood cells . it can be used in combination with autologous anti - cd19 - transfduced cd3 + cells . mantle cell lemphoma is a cancer that affects the immune system ( the body ' s natural defences ) and affects b - cells . in mantle cell lysis , b - lipocytes multiply in an uncontrolled
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - have ever had a problem with the number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 ) - have a problem of white cells in the blood ( autologous use ) - are having tests or checks of your lungs , heart , kidney , blood pressure , infection or inflammation - have problems with your cancer ( graft
tecartus is made from your own white blood cells . your cells will be collected by a specialised healthcare professional . your white blood will be given to you by a catheter placed in your vein ( a procedure call leukapheresis ). the amount of your whiteblood cells in your blood will then be diluted before being given to your doctor . tecartus will be administered to you in a hospital or clinic . it is given to patients 3 to 6 weeks after the last dose of your normal dose . the number of yourwhite blood cells will then slowly decrease over the next 2 to 3 weeks . medicines given before te
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you notice any of the following side effects you may need urgent medical attention . the following serious side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness , decreased level of consciousness ), confusion , memory loss , disturbances of brain function
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . infusion bag : store in the original package in order to protect from light . liquid nitrogen : the product should be used within 150 days . this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours at 2 - 10 . do away with the vial and any unused medicine .
what tecartus contains the active substance is autologous anti - cd19 - transduced cd3 + cells . each specific single infusion bag contains a dispersion of anti - cd19 car t cells equivalent to 68 cd3 cells per 2 ml of solution , corresponding to a concentration of 106 cd3 / ml anti . the other ingredients are sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartucus is a concentrate for solution for infusion . it is supplied as an infusion bag in a metal cassette . a single
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas or glit
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi : - if any of these apply to you ( or you are not sure ), talk to the doctor or nurse before taking this medicine . see also section 4 for further information . - if the medicine has been associated with blistering of the skin ( bullous pemphigoid ). janura
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg film film - coating tablets . your doctor will tell you the dose to take . you should take this tablet once daily . your dose may be adjusted by your doctor if you take this other medicines to lower blood sugar . diet and exercise can help your body use its blood sugar better . januvia can be taken with or without
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which might reach through to your back , with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate and sodium stearyl fumarate . the tablet film - coating contains poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide . what januva looks like and contents of the pack
xultophy works by lowering the amount of blood glucose produced by the body . this is important to help control the level of sugar in your blood . type 2 diabetes mellitus is a type of diabetes where your body does not make enough insulin to control the levels of sugar . your body also makes too much of the insulin it produces . this results in a high level of blood sugar . insulin degludec is a long - acting basal insulin . it helps to control your blood sugar levels . liraglutide ( a type in diabetes ) is a low - acting insulin during meals . xultophy may be used
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if you 39 are taking a sulfonylurea , glimepiride or glibenclamide . your sulfonylation dose should be reduced to a minimum of one tablet daily to control your blood sugar levels . warnings and precautions talk to your doctor or pharmacist before taking xulturo if you have type 1 diabetes mellitus or ' ketoacidosis '. this is a condition which can occur during treatment with xultide
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your blood sugar level . the recommended dose of xultophy is 41 mg once a day . you should take xultue for at least 8 weeks continuously . you can take xupophy with or without food . you may take it with or just after a meal . you must take xcultophy with a pre - filled dial - a - dose pen . the dose counter shows the dose to be taken in steps of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common , may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . this could be a sign of serious hypoglycaemia ( which may cause brain damage ). if you have low blood glucose , your doctor may check your bloodugar level more frequently . if you experience signs of low bloodugar ( see hypoglycemia in section 2 ), contact your doctor . serious allergic reaction (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , use within 30 days . after opening , store in the original package in order to protect from light . after use within 21 days , use in children and adolescents do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect
what xultophy contains - the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime in 3 ml solution . each vial contains 300 units of the active substance of insulin gludec 10 . 8 mg liraaglunide . - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections . see section 2 " xultphil contains sodium ". what xultos looks like
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ) and her2 [ erbb2 ]- erbb3 . these proteins are involved in the growth of cancer cells . this medicine stops the growth and spread of cancer proteins and slows down their growth . this product is used to treat adults with cancer of the lung ( non - small cell lung cancer ). giotriff is used as your first treatment after receiving prior chemotherapy treatment for squamous type a when prior chemotherapy therapy has not
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( over 50 kg ) if your doctor has told you that you have kidney problems if you suffer from side effects associated with lung inflammation ( interstitial lung disease ) if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking giotrantif if : you have liver problems your doctor may need to do some liver tests before you start taking this medicine . you have a severe liver disease . you suffer or have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take this this medicine with or just after food . you may take this with or with food . the maximum recommended daily dose of this medicine is 1 tablet once daily . if you take more giotrinif than you should if you have taken more giurif
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotreif : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoeal ( see section 2 " warnings and precautions ") severe diarrhoehoea with or without fluid loss common ( might affect up in 1 in every 10 people ) low blood potassium ( see below ) worsening kidney function if you experience diarrhoee or diarrhoeas contact your doctor immediately , as appropriate antidiarrhoeal treatment may be needed . you should be given antidi
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatin ib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , water for injections . what giotreif looks like and contents of the pack giotriif 20 mg film - coating tablets are white , round , biconvex , and embossed
orkambi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years . f508del mutation ( a type of cyst fibrosis transmembrane conductance regulator ) is a protein that is found in the lungs . the mutation causes an abnormal cftr protein . lumacafor and / or ivacafir work together to remove the abnormal cFTr protein and replace it with lumacftor . lumaconaftor causes the abnormal protein
do not take orkambi if you are allergic to lumacaftor , ivacaftour or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that you have the f508del mutation , your doctor may need to change your dose of orkami . talk to a doctor if you suffer from liver or kidney disease . your doctor will monitor the dose of okambie . abnormal blood tests of the liver may be performed before orkibi is given . tell your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is one 6 mg tablet once a day . your doctor may increase your dose to one 12 mg orkambi tablet once daily for 6 to 11 weeks . your dose of orkammi is 100 mg once a week for 2 weeks . this means that your doctor will increase your daily dose to 2 tablets once a month . your daily doctor may reduce your dose up to one tablet once every 12 weeks . if you take more orkami than you should
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate . if you are given ivacaftor with orkyambi , you may experience serious side effects . these effects may be due to orkibi : raised levels of liver enzymes in the blood , which may increase the risk of liver injury in patients with pre - existing severe liver disease , or the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): the following symptoms may be associated with or kambi :
what orkambi contains the active substances are lumacaftor and ivacaftir . orkammi 100 mg film - coated tablets each tablet contains 100 mg lumacftor and 125 mg ivacftir . each tablet of orkmbi 200 mg film film - coating contains 125 mg lumiacaftor or 125 mg of ivacaptor . each film - coat of orkyambi 100mg film - containing 125 mg orkibi 200mg film film coating contains 200 mg lumacyaftor ( as ivacafor ). each tabletof orkabi 100 μg film -
what lynparza is lynparaz contains the active substance olaparib . olaparateib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ) that works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors cause death of cancer cells by blocking an enzyme needed to repair dna . what lynparzar is used for lynparparza has been prescribed for the treatment of ovarian cancer ( brca - mutated ovarian cancer ) in patients who have not previously responded
do not use lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using lynparze if any of these apply to you . if you think any of this applies to you , or if you have any further questions on the use of this product , ask your doctor or pharmacist . children and adolescents do not give this medicine to children under 6 years of age . other medicines and lynparz tell your doctor if you or your child are taking , have recently taken or might take any
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . the dose may be increased to 150 mg once daily . the doses of lynpalza capsules taken together with tablets may be adjusted to suit your specific needs . if you take more than a capsule of lynarza daily than you should if you have taken more than the prescribed dose , you may experience side effects . how to take take the capsules at about the same time each day . take the capsule about 8 hours before or after
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions including hives , difficulty breathing or swallowing , dizziness . if you notice any of these , please tell your doctor . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 30 . store the capsules in the original package in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparateib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack lynparparza is a white , opaque , hard capsule imprinted with " olaparaib 50 mg " and " astrazeneca logo on one side . lynparanza is available in packs containing 112 hard
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine in adults . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose in adults , adolescents and children aged 14 years and above . opioid overdose is a serious , life - threatening , and sometimes fatal , overdose . it can cause breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get emergency medical care .
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose may be similar to those of an overdose . if you use more nyx than you should if you accidentally use more than the recommended dose , contact your doctor or the nearest hospital emergency unit immediately . if possible , show them the new nasal spray you have used . if this
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one spray once a day . 1 . if symptoms are not present , use the spray in the shoulders , ears , breastbone , sternum or inside the ear . do not use the nasal spray if you notice any of the following : clear the mouth and nose of any blockers . do this by gently pushing the spray into the mouth or nose . 1 ) if breathing is the chest moving ( e . g . chest ) you can hear breathing sounds and breath on the cheek
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms ( possibly caused by opioid drugs ). symptoms may include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100 people . these symptoms are
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone . - the other ingredients are : ( hydrochloride dihydrate ), trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . what nyxoids looks like and contents of the pack nyxoidal is a 0 . 1 ml clear , colourless to pale yellow solution for injection in a pre - filled nasal spray . it is supplied in a single dose container . nyxax is available in a carton containing 2
what ovaleap is ovaleep contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is similar to a hormone produced naturally in the body ). follitroin ala is a hormone that plays an important role in the growth and development of the sacs ( follicles ) in the ovaries . follitroline is involved in the production of sperm and is produced by a immature egg cell . ovaleaps is used in women who are not ovulating and who are undergoing treatment with a medicine called " clomifene citrate " and who
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ). if you think you have large ovaries or sacs of fluids that contain the ovaries ( ovarian cysts ). if unexplained vaginal bleeding . if you know you have cancer in your ovaries , womb or breasts . if any condition that makes normal pregnancy impossible . if your doctor thinks you have ovarian failure ( early menopause ). if your womb has
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use this medicinal product is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you will usually receive this medicine within the first 7 days of your menstrual cycle . the medicine will be given to you by your doctor . the recommended dose of this medicine is 75 mg once a day . your doctor will tell you how many days you should take it . the usual dose is 150 mg once daily . you will normally receive this medication for 7
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 this is uncommon ( may affect up to 1 in 10 , 000 people ). if you have this type of reaction , your ovaleAP injection should be stopped immediately . serious sideeffects in women lower stomach ache and nausea ( vomiting ) are the symptoms of ovarian hyper - stimulation syndrome ( oh
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do this medicine if it is stored at room temperature ( up to 30 ) for a single period of not more than 3 days . once the cartridge has been removed from the refrigerator and has
what ovaleap contains the active substance is follitropin alfa . each cartridge of ovaleep 300 iu / 0 . 5 ml solution for injection contains 300 iiu ( 22 micrograms ) follitroin ala in 0 . 05 ml solution . each carton of ovatheap 450 iu/ 0 . 75 ml solutionfor injection contains 450 iiu 33 microgram ( 23 microgram ) follitonropin alpha in 0. 75 ml . each box of ovoneap 900 iu ( 1 . 5ml ) solution for injections contains 600 iu of follitruin alga
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp .) and candidaemia ( a form of fun fungal illness caused by candida sp .) in non - neutropenic patients with abnormally low white blood cells count . candida spores infections are caused by the fungus fluconazole ( another antifaunal
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any other medicines , including herbal medicines . the medicines listed below may affect the way voricoazole accord treatment works . 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in treating stomach problems ) pimozide ( used when treating mental illness ) quinidine ( used if you have irregular heart beat ) rif
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . the dose may be increased by 400 mg once daily for 12 hours or 24 hours or 200 mg twice daily for 24 to 24 hours and 100 mg twice weekly for the first four weeks of treatment . the recommended dose is 300 mg once per day . if you have mild to moderate cirrh
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice ( changes in blood tests of liver function ), pancreatitis . other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual aura , visual ac
what voriconazole accord contains the active substance is vorinazole . each tablet contains 50 mg voronazole ( as besilate ). voricoazole accord 50 mg film - coated tablets : each tablet has 200 mg vorbiconazose ( as mesilate ) the other ingredients are : tablet core : voricazole acord 200 mg film film - coating : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to adults and children from 1 year of age with ebolairus . it will be given to you as a 2 - dose course of vaccinations . the other ingredients are : ebola virus disease : the zaire ebolavirus and filovirus . this vaccine contains less than 1 million international units ( iu ) of filov virus . the whole ebola viruses are present in the body . this will give you ebola viral disease . warnings and precautions talk to your doctor or nurse before you are given m
your doctor will decide on the best dose for you . the vaccination course should be started by a doctor who is experienced in the use of the vaccine . if you have had a severe allergic reaction to any of the ingredients in section 6 . if a severe allergy reaction to an antibiotic called ' gentamicin ', may occur , the vaccine should not be given . if any of these apply to you ( or you are not sure ), talk to your doctor or nurse before you are given mvabea . if your doctor has told you that you have a severeergic reaction , please tell your doctor . if this applies to you , tell
the recommended dose is one injection into a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the recommended dose of vaccination is one dose of zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine will be given as an additional dose . the first dose of vaccine is given as a single dose . primary vaccination first vaccination with zab deno red cap vial ( 0 . 5 ml ) second vaccination with mvabdenos yellow cap vials ( 0. 5 ml ). if you have received more than 4 months ago
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling or where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) being sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness , skin hardness or where where the needle is given generalised itching . the most common side effects are : common ( will affect up in every 1
what mvabea contains the active substance is zaire ebolavirus 29 produced in tai forest ebolovirus nucleoprotein marburg in 0 . 7 ml of solution for injection ( antigen ) 108 produced in chicken embryo embryo fibroblast cells . the other ingredients of this vaccine are trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what mvagaa looks like and contents of the pack mvaraa is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce the risk of other bone problems that may need surgery or radiotherapy bondronat is used if you have a raised calcium level in your blood due to a tumour . it reduces the amount of calcium that is lost from your bones . this helps to stop your bones getting weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronate if you : have a rare side effect called osteonecrosis of the jaw ( onj ), which can lead to bone damage in the jaw . your doctor may decide to reduce your dose of bondronatin if you suffer from cancer or related conditions . onj can be life - threatening and may be fatal . stopping treatment for onj may be
this medicine is given to you by a doctor or nurse who is experienced in the treatment of cancer . it is given as an infusion into your vein . your doctor will do regular blood tests before you are given bondronat . your dose of this medicine will be adjusted depending on your illness . if you have breast cancer that has spread to your bones , it will usually be given every 3 weeks . however , it may take up to 3 - 4 weeks . your first dose will be given as a single dose as an injection in your vein over about 15 minutes . if there is a raised calcium level in your blood , it can be
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 in 10 , 000 patients ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc to 8ºc . do away with this medicine if you notice any particles in the solution .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack 1 ml vials are white to off - white , round , bromobutyl rubber stopper .
what zeposia is zepoia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ) in the body . what zepoesia is used for zeposeia is a treatment for relapsing remitting multiple sclerosis ( rrms ), a type of active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsING remitting ms is attacks on the nerve cells . the symptoms usually disappear for a few days or weeks , but some problems may be serious . how zeposes
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if your heartbeats ( arrhythmia ) are not normal . if any of these apply to you , tell your doctor before treatment . if the patient has severe infection such as hepatitis , tuberculosis or cancer . if he / she has severe liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need and will work it out based on your heart rate . your doctor may also prescribe you a ' treatment initiation pack ' with orange capsules . the first 4 days of treatment each capsule contains 0 . 23 mg ozanimod . the next 1 day of treatment will be followed by 4 days ' rest period '. the next 3 days will be interrupted by 3 days ' resting period '. your doctor might prescribe you 0 . 46 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : common ( may affect up to 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure ) uncommon ( may effect up to1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very common ( might affect more than 1 in10 people ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) and voice box ( larynx ). viruses and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in the original package in order to protect from moisture . do do not take this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0 , 46 mg : one capsule contains approximately 0 . 46 mg ozimod ( as hydration ). ozanimode is also available as hydro chloride . ziposia 0. 92 mg : two capsules contain approximately 0.92 mg ozomonod (as hydrochlorine ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium
what temybric ellipta is temybarric elliptic contains two active substances called fluticasone furoate and umeclidinium bromide and vilanterol . fluticusone fureate belongs to a group of medicines called corticosteroids ( steroids ). umeleclidinnium bromeide and Vilanterrol belong to agroup of medicines known as bronchodilators . what temyborric elliptical is used for temyberric elliptaic is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric ellipte - if your child has asthma . temyberric elliptoe should not be used in children with asthma . - if the child has heart problems , high blood pressure , liver problems . - tell your doctor if your baby has tuberculosis ( tb ) of the lung , or any long standing or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the usual times . you can use tembricipta any time of the day , with or without food . if you have symptoms of temybreric elliptoe such as a sudden attack of breathlessness or wheezing , stop using the inhaler and seek medical help immediately . if your symptoms do not improve
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing does not improve after taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) in copd is a common side effect of temybric ellipta . symptoms of a lung infection may include fever and chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat caused by a fungal infection ( candidiasis ) when
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umeklidinum bromides and 55 microgram s of umclidiniaium bromeide and 22 microgramS of vilancerol ( as trifenatate ). the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium stear
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues below the skin . it is used to treat an infection of the lungs called ' pneumonia '. how zininforoe works zin foro works by killing certain bacteria that cause serious infections .
do not use zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before using zin foro . if any of these apply to you , tell your doctor before using this medicine . warnings and risks talk to the doctor or nurse before using it if you : have kidney problems . have
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many doses to give . the recommended dose is one 600 mg tablet once a week for up to 8 weeks . if you have some infections that you may need to stop taking zin for 8 weeks or 12 weeks , your doctor may give you a lower dose . zinforto is given as a drip into a vein ( intravenously ) over a period of 5 minutes . your dose may be increased to 60 mg or 120 mg once every two weeks . your physician will tell how many tablets you need to take . your first
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects . if you get any of these symptoms , you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems , asevere allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . your doctor may decide to stop treatment with zinforo or to give you medicines to slow bowel movement ( see section 2 ). this may take up to 1 in 10 people . your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do this to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine and water for injections . what zinofo looks like and contents of the pack zinfforo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . zinfoo is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin polizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic Pain , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with mood
do not take pregabalin pfizer - if you are allergic to pregibalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregagabalin pumpfizer . some patients taking pregaabalin prefizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregazalin has been associated with dizziness and somnolence , which could
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy and generalised anxiety disorder the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregibalin psfizer . take pregaboralin pfeizer once in the morning and once inthe evening . swallow the capsule whole with a glass of water . you can take pregaabalin with or without food . if you
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregaboralin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1521 ), potassium hydroxide ( e433 ).
xadago is a medicine that contains the active substance safinamide . it works by reducing the amount of dopamine in the brain . this is important in helping your brain work better . it is used in adults with parkinson ' s disease . in parkinson's disease , sudden swings in movement may affect many people not able to move . this can lead to difficulties moving . xadago can be used alone or in combination with the medicine levodopa ( other medicines used to treat parkinson' s disease ).
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed any of any of these medicines : monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , and tranylcypromine . these are all used in treatment of parkinson ' s disease or depression . - pethidine ( a strong pain killer ). if you have had problems with your retina
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg once a day . the dose may be increased to 100 mg once daily by mouth . your doctor will tell you how many tablets of xADago to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . if your doctor thinks that the effect of xademark is too strong or too weak , talk to your doctor . xadadago should be taken with caution . if taking more xadagon than
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure that may lead to collapse ) has been reported very rarely in patients with neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported in patients treated with parkinson ' s disease , when used in combination with safinamide or levodopa . the following effects have also been reported with other medicines used to
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinam . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ). what xadag looks like and contents of the pack xadagon 50 mg film - coated tablets of 7 mm diameter with metallic gloss are white , round , biconc
zytiga contains a medicine called abiraterone acetate which is used to treat prostate cancer in adult men whose body does not produce enough testosterone to control prostate cancer . zytiga is used in adult women whose disease has not responded to hormone therapy , a treatment that lowers testosterone ( androgen deprivation therapy ). it is used together with another medicine , prednisone . prednisolone is used for high blood pressure in adult patients whose body is not producing enough testosterone ( fluid retention ) to control the level of testosterone in your blood .
do not take zytiga - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - if your pregnant or breast - feeding is not recommended . warnings and precautions talk to your doctor or pharmacist before taking zytig if you have severe liver damage or prostate cancer . this medicine should not be taken with this medicine . if you think any of these apply to you , tell your doctor before taking this medicine : - if any of your medical conditions apply to your ( or your child ' s ) health , tell them before taking it . - if they
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at the same time each day . this medicine should be taken by mouth . you can take it with or without food . if you take more zytiga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablets with food . you may need to take zytige for 2 weeks before you start taking zytig . swallow the tablets whole with a glass of water
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . these may be signs that the level of potassium in your blood is low . your doctor may check your potassium regularly . other side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( see section 2 ' warnings and precautions '). low blood potassium ( seen in liver function test ). high blood pressure . urinary tract infection . diarrhoea . common
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytige looks like and contents of the pack - zytigiga tablets are white to off - white , round tablets with " 9 . 5 " debossed on
hefiya contains the active substance adalimumab , a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedile crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . ad alimumab attaches to a specific protein called tumour necrosis factor ( tnfα ). tnfsα is a protein that is involved in the inflammatory diseases and in reducing
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child ' s child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections ( unusual infections caused by a weakened immune system ). symptoms of infections may include fever , wounds , feeling tired , dental problems . if your / your child has moderate or severe heart failure . if you or your or his child has had a serious heart condition . warnings and precautions allergic reaction if your , or your / his child 's child
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor may prescribe a different dose for you . the dose may be increased to 20 mg , 40 mg , 20 mg or 40 mg depending on your condition . polyarticular juvenile idiopathic arthritis age and body weight how much to take adults , adolescents and children from 2 years of age weighing 30 kg or more 40 mg once a week . children from 1 year of age to 2 years weighing 10 kg or less 30 mg once daily 20
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 ) since the last hefiya injection : allergic reaction ( including heart failure ). severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . tell a doctor straightaway if you have any of these signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe may be kept at room temperatures ( up
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adaluma in 0 . 4 ml of solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiah 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear type
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target of this target , it stops the cell from growing and dividing . what ritemby is used for ritemira is used to treat adults with a ) non - hodgkin ' s lymphoma . this is an autoimmune disease of the lymph tissue that affects the immune system . it affects a type (
do not take ritemvia if you are allergic to rituximab , other proteins that contain ritukimab . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : are 6 years of age or older have a severe active infection with a weak immune system have severe heart failure have severe uncontrolled heart disease have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris have any of the following conditions : ritemvir can cause a hepatitis infection . ritemv can cause hepatitis b to become active again , which can be
how much ritemvia is given your doctor will decide how much ritemvia you will receive and how often you will need to have this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may lower your dose . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritemvi administration you will be given ritamvia together with other medicines ( pre - medication ) to reduce the risk of side effects . your doctor or nurse will decide the
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing or palpitations , heart attack , low number
what ritemvia contains the active substance is rituximab . each ml contains 100 mg of ritukimab ( as besilate ). each ml of concentrate contains 10 mg of the active ingredient ritiximab ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemva looks like and contents of the pack ritemv is a clear , colourless solution for infusion in a glass vial . pack size of 2 .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabrine teva contains capecitibine , which itself is not a cytostolic medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine tacva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitabiline teeva is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . cape citabineteva may be
do not take capecitabine teva if you are allergic to capecitabiline or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice before taking this medicine . if you have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines containing fluorouracil ) if you ( or your partner ) are pregnant or breast - feeding if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia , thrombocytopenia ) if your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva is based on your body surface area ( height and weight ). the usual dose is 1250 mg / m2 of body surface surface area taken once daily . this is for example : - if you weigh 64 kg or height ; - if your height is 1 . 64 mbq ;
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you get any of these symptoms : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movements each day . if you develop any diarrhoehoea at night , stop taking the medicine and seek urgent medical advice straight away . vomiting : if your vomit is more severe than nausea , you may lose your appetite . stomatitis : if pain , redness , swelling or sores in your mouth and / or throat , especially
what capecitabine teva contains the active substance is capecitabiline . capecitibine teeva 150 mg film - coated tablets each film - coating contains 150 mg capecitobine . furthermore , capecitafine tevas 500 mg film film - coat contains 500 mg capectabine . the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hyproellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red (
silodosin recordati contains silodosino recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordi is used to lower the pressure in the prostate , bladder and urethra . it helps to maintain smooth muscle in these tissues . it also helps to reduce your symptoms . silosin Recordati is used in adults to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water , and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if your child is undergoing eye surgery - if the doctor has noticed cloudiness of the lens during cataract surgery 26 - if any of these apply to your child , tell your doctor . silodosiin recordat may not be suitable for your child . - if a doctor has prescribed medicine to prevent a loss of muscle tone in the iris ( the coloured
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of silodosin recordati taken once a day for 8 days . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodosein recordat is taken once daily for 4 days . swallow the capsule whole with a glass of water . if taking more silodosesin recordi than you should if you feel dizzy or feel weak , talk to a doctor or go to a hospital straight away
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin or hives are the most common side effect of silodosin recordati . dizziness . dizzy and occasionally fainting may occur . if you feel weak or dizzy , tell your doctor . the symptoms may include dizziness and faints . if any of the above applies to you , tell the doctor or pharmacist . if a dose of silosinrecordati is missed or you experience complications after a cataract surgery
what silodosin recordati contains the active substance is silodusin . each capsule contains 8 mg silodosein . the other ingredients are : capsule content : silodasin , mannitol , magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). capsule shell : silosin filmati 4 mg silosino , mannaitol , aluminium stearates , sodium lactilsulfATE , gelatin, titanium dioxide , yellow iron oxide ( e172 ). what silodosiin recordat looks like and contents of the pack silodnosin recordi 8
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is caused by a combination of several causes . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead
do not take kinzalmono if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). if you think this applies to you , tell your doctor before taking kinzalmol . if you ( or your child ) are more than 3 months pregnant ( it is also better to avoid kinzdalmono in early pregnancy see pregnancy section ). if your or your baby ' s doctor has told you that you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed whole with some water . you can take kinzalmono with or without food . try not to take more tablets than your doctor tells you to . if you take more kinzdalmono than you should if you have accidentally taken too many tablets , contact your doctor immediately . treatment of high blood pressure the usual starting dose of kinzaline 40 mg once a day
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious and need immediate medical attention : sepsis ( blood poisoning ) is a severe infection with whole - body inflammatory response that can cause rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) reduction in cardiovascular events uncommon side effects : uncommon ( may impact up to one in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . once your medicine has been taken out of your refrigerator , it should be used immediately . do this by gently squeezing your kinzalmono tablet out of its blister . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol , magnesium stearate . what kinzalao looks like and contents of the pack kinz almono 20 mg tablets are white to off - white , round and flat . kinzaloo is available in blister packs of 14 , 28 , 56 , 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa . afstylfa is used to treat bleeding episodes in adults with haemophilia a ( inborn factor v iii deficiency ). factor vii is a naturally occurring component of blood clotting . it helps blood to clot . afstona has an increased tendency to bleed . factor v viii is important in all types of haemilia a to help blood clot . your doctor has prescribed afstyra for you because you are not able to clot it properly .
do not use afstyla if you have had an allergic reaction to afsty or any of the other ingredients of afstylea ( listed in section 6 ). if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afsteya . the batch number and frequency of administration are recorded in your treatment diary . do not use more afstilea than your doctor tells you to . allergic ( hypersensitivity ) reactions are possible with afstrya . symptoms of allergic reactions may include : allergic reactions such as hives , generalised skin rash , tight
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of afstyla is one vial per day . dose and duration of treatment depending on the severity of your disease the site and the bleeding your clinical condition will be decided by your doctor . frequency of administration general instructions the powder and the solvent ( liquid ) should be mixed in a separate vial to avoid aseptic conditions . afstlva may be used with other medicines or sol
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding caused by high levels of factor viii medicines ). inhibitor antibodies ( see section 2 ) may affect up to 1 in 10 people . patients who have received previous treatment with factor v iii ( more than 150 days of treatment ), the risk of developing a condition called " inhibitor antibodies " (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . keep afstylea in theouter carton to protect it from light and moisture . the reconstituted
what afstyla contains the active substance is lopidocog . each vial contains 250 iu ( 2 . 5 ml ). after reconstitution with 2 .5 ml of water for injections the solution contains 200 iu lonoctocog alfa . each 1000 iu vial provides one injection of 2 . 25 ml of solution for injections . each 400 iu / ml vial delivers one injection in the form of lonoectocog alpha . each 1500 iu per vial provide one injection . after reconitution with 5 ml of solvent for injections , the solution provides 400 iiu l
what praxbind is praxBind contains the active substance idarucizumab . idarucaizumb is a recombal agent . it is similar to dabigatran ( pradaxa ), but is a blood thinner medicine used to prevent blood clot formation . what prax bind is used for praxbinding is used to rapidly trap dabigitran . what it is usedfor prax Bind is used in adults . it can be used : - when you are being treated with pradxa , you may be admitted to hospital for emergency surgery or urgent procedures to control uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( haf ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking this medicine . taking this type of medicine dabigatran with other medicines may increase the risk of blood clots . dabigitran is a substance that is absorbed by the body and can form blood cl clots , which can be fatal . medicines to prevent blood clclots may be
the recommended dose is 5 mg / kg ( equivalent to 2 . 5 mg dabigatran ). this medicine will be given to you once a day . you will be monitored for the development of blood clot formation . you should be given the recommended dose of dabig at least 5 mg per day . this medicine is given into a vein . you may be given this medicine at any time during your treatment . if you have problems with blood clotformation , dabigATran may be administered less than 24 hours after you have been given this dose . if any of the above apply to you , tell your doctor or nurse before you are
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what prax bind looks like and contents of the pack praxbinding is a clear to slightly opalescent , colourless to slightly yellow solution supplied in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and then together with monotherapy phase oftreatment ( phase 3 ). - in children with malignant glioma , such as glioclastoma multipurpose or anaplastic astrocytoma . temmedac is given in combination with standard treatment .
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing and swelling of the face , lips , tongue or throat . if you notice any of these signs of a possible allergic reaction , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before taking temomedic : if you : have had a severely reduced ( myelos
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take with temomedic to prevent nausea and vomiting . if you currently have newly - diagnosed glioblastoma multiforme , treatment will be divided into two phases : treatment with radiotherapy ( concomitant
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures ( convulsions ), fever , chills and severe headache , stop temomedac treatment and seek medical help immediately . there may be a reduction in certain kinds of blood cells . this can cause increased bruising or bleeding , anaemia ( a shortage of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived . in some cases , it may be prolonged
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with the capsules if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . temomedic 5 mg : each capsule contains 5 mg temozoleomide ( as mesolomides ). temomediac 20 mg : one capsule contains 20 mg tem ozolomine ( as temolomid ). temmedac 100 mg : two capsules contain 100 mg temzolomile ( as Mesolomix ). temarthac 140 mg : three capsules contain 140 mg temuzolomime ( as besolomod ). temothac 180 mg : four capsules contain 180 mg temizolomage ( as
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis will only help you to obtain a hard erect penis if you have agreed to it . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by helping the blood vessels in your penis to relax . this helps your penis relax and allows you to have sex . it is important that you continue to take cialises for as long as your doctor tells
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are taking organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali . if you have recently had a heart attack or in the last 90 days . - if recently had or have had a stroke in the previous 6 months . - you have low blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the usual dose is between 5 mg and 2 . 5 mg . if you take more cialises than you should if you accidentally take too many tablets , contact your doctor . if possible , show them the pack . if necessary , show the doctor the pack of tablets . if not , show it to your doctor ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain ( see section 2 ) nitrates ( frequency unknown ) priapsim may cause a prolonged and possibly painful erection . stop taking cialis and seek medical help straight away if you get an erection that lasts longer than 4 hours . contact your doctor immediately if you experience sudden loss of vision ( frequency cannot be estimated from the available data ). other side effects very common ( may affect more than 1 in 10 people ) uncommon ( may affects
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), ironoxide red ( e 172 ),
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not produce enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglID is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your blood blood sugar may also be increased when eny glid is taken in combination with metformin . if you have diabetes , eny
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low . if you suffer from diabetic ketoacidosis ( see section 4 ). if your doctor has told you that you have a severe liver disease . if your dose of gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . if any information applies to you ( or you are not sure ), talk to your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg once daily . your doctor may increase your dose to 4 mg once every 30 minutes . your daily dose may be increased to 16 mg once weekly depending on your response to the medicine . if you take more enylid than you should if you accidentally take too many eny glid tablets , or
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid is hypoglycasemia ( which may affect up to 1 in 10 people ). hypoglycemic reactions are generally mild / moderate . however , hypoglycanemic unconsciousness may lead to coma . allergy allergy ( rare , may affect 1 in every 10 , 000 people ) symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating ( anaphylactic reaction ). other side effects include : common ( may affect more than 1 in10 people ): stomach
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg or 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) only in 1 mg tablet and red iron oxide (< e172 ). only in 2 mg tablet . what eny glid looks like and contents of the pack enyGlid
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine myla is used for azaciticidine myel is used to treat adults . what it is usedfor azac citidine mylon is used in adults . azacididine mylin is used after a stem cell transplantation in adult patients with higher - risk myelodysplastic syndromes ( mds ). it is also used in adult adult patients to treat chronic myelomonocytic leukaemia ( cmml ) and acute myeloid leukaemic (
do not take azacitidine mylan if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). if you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine mylan : if you suffer from decreased counts of platelets , red or white blood cells . if you know that you have kidney disease . if your doctor has told you that you suffer too much from liver disease . warnings , precautions and precautions tell your doctor if you : have a heart condition , have ever had heart attack or have lung disease .
before starting azacitidine mylan you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azaccitidine myl you need . your dose of this medicine will depend on your height and weight . azacacitine mylan will be used every day for 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising ( which may be symptoms of liver failure ). swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( which could be symptoms due to kidney failure ). a fever ( which might be a sign of an infection due to low levels of white blood cells ). chest pain
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be used within 1 hour . the azacididine myla suspension must not be mixed with water for injections . thesuspension must be stored in a refrigerator ( 2 8 ). do not freeze . the zacitine mylan suspension must either be stored at room temperature ( up to 25 ) or in a freezer ( up up
what azacitidine mylan contains - the active substance is azacinidine . one vial of powder contains 100 mg of azacita . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaciticidine . - the other ingredient is mannitol ( e421 ). what azaccitidine myl looks like and contents of the pack azacitonidine mylon is a white powder for suspension for injection in a glass vial containing 100 mg azacitasidine . pack sizes of 1 or 7 vials . not all pack sizes may
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprost is a prostaglandin analogue in the eye . timolole is a beta blocker that reduces the amount of fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . - if the child has wheeziness , difficulty in breathing , or long - standing cough . - breathing problems suchas severe hay fever . - tell your doctor if your baby has a slow heartbeat . - talk to your doctor before taking duotra if your newborn has heart failure ( a disorder of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye once a day . do not use duotrav in both eyes . do this if your doctor tells you to . duotrave is for oral use . use in adults and children the recommended doses are one drop twice a day in the morning and one drop once a night in the evening . use duothrav in the eyes once a week . use the recommended daily dose of duotrev in adults . use it in combination with other eye drops . how to
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops may not work very well and may cause you to stop using duotrav . very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness . common side side effects these may affect up to 1 in every 10 people ). effects of of theeye eye surface inflammation ( surface damage ) including eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs and symptoms may include eye irritation , burning and stinging . uncommon side effects this may affect upto 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do away with the blister after 4 weeks to prevent infections . do this every time you take duotrav . do you have any further questions on the use of this medicine , ask your pharmacist .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg of travostrost and 5 mg of timolole ( as timololed maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg / ml . - the ingredients are : boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . acidity levels are measured using aciditylevels and ph levels
nplate ' s active ingredient is romiplostim . it is a protein used to reduce low platelet counts caused by the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are important in protecting your blood from blood clots . very low platelets can cause bruising and serious bleeding . nplate is used in adults , adolescents and children aged 1 year and above who have had their spleen removed . itp can also be used in patients with chronic itp who
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . if you have been previously treated with other medicines containing escherichia coli ( e . coli ). warnings and precautions some people taking nplate have a low blood platelet count ( thrombocytopenia ). nplate may reduce your platelet counts . this is especially important if you : have a history of blood clots . you have a risk of blood clotting . have liver problems . are over
nplate is used in adults and adolescents ( aged 1 to 17 years ) who are already taking nplate . your doctor will decide how much nplate you need . nplate is given as an injection under the skin ( subcutaneous ) ( see section 1 ). how much and how often you need to take nplate your doctor may decide to increase your dose of nplate depending on your platelet counts . your dose will be calculated using regular blood samples taken to measure the number of your platelets . your platelelet count will be checked regularly . your blood will be taken regularly to check your plate clotting . your usual
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache allergic reaction upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder ( increased bone marrow fibres ) trouble sleeping ( insomnia ) dizziness , tingling or numbness of the hands or feet ( paraesthesia ) migraine , redness ofthe skin ( flushing ) blood clot in a lung artery ( pulmonary embolism ) nausea , diarrhoea , abdominal pain , indigest
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains 230 mg romipliplostime . each vial of 125 mg romplostim contains a deliverable amount of 0 . 25 ml solution . each single - dose vial contains 125 mg of romiplose . each multi - dose dose vials of 375 mg romoplostim contain 250 mg of the active ingredient romiplOSTim . each dual - dosevial of 500 mg contains 375 mg of of romploseim . every single -dose vial containing 500 mg of templostime
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help to relieve breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on copd .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - kidney problems - an eye problem called narrow - angle glaucoma - difficulty passing urine . your doctor may decide to temporarily stop treatment with tovannor breezer . if you have any of these conditions , stop using this medicine and tell your doctor immediately : - tightness of the chest , coughing , wheezing or breath
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is 24 capsules ( 75 capsules ) once a day . you should use this leaflet exactly as described in this leafleting guide . you can use this medicinal leaflet or with your partner ' s advice . how to use this product the recommended starting dose of using this medicine for adults is one capsule ( 75 micrograms ) once daily . you will need to use it for as long as your prescribed dose . this
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopromroniumbromide and 50 microgramms glycopYRronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgramrams glycopyronium per inhalation dose . - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44 microlit
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as ( schizophrenia ) hearing , seeing things which are not there ( mistaken beliefs ), incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . adasve may also be used
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvet ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking adasuvest if you have lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortness of breath ( nms ) 25 if you suffer from neuroleptic malignant syndrome ( n ms ), which can be life - threatening and can
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( taken in 2 to 4 . 5 hours ). if your condition worsens , your doctor may prescribe a lower dose . adasuve is for oral use . you should take adasuves with food . you can take adasve with or without a meal . it is best to take adamsve with a glass of water . try to take your tablet at the same time each day . you may find it easier to take it with food ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , which may become irritating . these may be signs that your airways are not working properly ( asthma or copd ). - light - headedness or fainting . these could be signs of a lowering of your blood pressure . - worsening agitation , confusion , fever and muscle stiffness . these can be signs for a severe condition called neuroleptic malignant syndrome . other
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and on the blister after exp . the exp expiry day refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with adasuves if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxapeine . one single - use delivers 4 . 5 mg loxideine . what adasuves looks like and contents of the pack adasuva 4 . 0 mg is a white to off - white plastic inhaler , with " lox " printed on the cap and " gsi " printed in black on the body . each inhaler is packed in a sealed foil pouch . adasuvel 4 . 4 . 95 mg is available in packs containing 1 or 5 inhalers . not
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent which belongs to a group of medicines called ' anti - metabolites '. what azaccitidine betafarm is used for azaciticidine betaparm is for use in adults . azacididine betagarm is given to adults who have had a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myelomonocytic leukaemia ( cmml ) acute myeloid leukaemic ( aml ). these are diseases that
do not use azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before using azacacitine betapham : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition that makes you prone to heart attack or lung disease . blood
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how much azaccitidine betafarm you need . your dose of this medicine will be adjusted by your doctor based on your height and weight . azacacitine betapham will be used every day for 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given under the skin ( subcutaneously ) on the skin of your thigh , tummy or upper arm . if you have any further questions
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice ( e . g . abdominal bloating and easy bruising ), which may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue , which may also be symptoms , of kidney failure . a fever , which might be a sign of an infection with low levels of white blood
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . any unused azaccitidine betabarm must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be used within 45 minutes . the azacituidine betafarm suspension must not be mixed with water for injections . the solution must be stored in a refrigerator ( 2 8 ). the azacsitidinebetapharm suspension should not be stored with water or injections . it must be kept in a freezer ( 2 - 8
what azacitidine betapharm contains - the active substance is azacitonidine . each vial contains 100 mg azacitasidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol ( e421 ). what azacituidine betafarm looks like and contents of the pack azaciticidine betabarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacita .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher dementia type 1 is inherited condition in which a substance called glucosylceramide is not removed from the body . this substance is mainly produced by the spleen , liver and bones . when eliglustate is taken with glucoslceramide , it stops the production of glucosyleceramide and helps your affected organs to function normally . your doctor will test for this medicine before you start taking cerdelga . if you use more cerdelaga than you should if you
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - if your body is not able to tolerate medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 - if it is not possible to tolerate moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). your doctor will tell you whether you can tolerate these medicines , or whether you need to change your dose to improve your body ' s ability to tolerate cerdelg . warnings
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of metaboliser twice a day . the dose of metabolizer is one 84 mg tablet once a day , taken at the same time each day . swallow the tablet whole with a glass of water . if you take more cerdelga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take the tablet pack with you . do not open the blister / wallet . take the sleeve with your thumb or finger . pull down the blister/ wallet
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelgi looks like and contents of the pack cerdelg capsules are a peach
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the original bone ). it reduces the amount of calcium in the blood in adult men when a tumour has formed . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . do not use zoledron acid hospir - if you are allergic ( hypersensitive ) to zoledic acid , another bisphosphonate ( the substance to which zoledicle acid belongs ) or any of the other ingredients of zoledor acid hospire ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using zoledric acid hospiro if you have or have had a kidney problem . if you experience pain , swelling or numbness
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ) and in accordance with official guidelines for ' iv ' administration . in order to avoid dehydration , you must drink plenty of fluids before and during treatment with zoledronic acidic hospira ( see section 4 , " how to prepare and use zoledron acid hospir "). if you have a kidney problem , your doctor may decide to reduce the dose you receive . if your kidney problem is not controlled with zolingronic acidospira , you may be at increased risk of bone complications ( bone
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common side effects are : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ) low level of calcium in the blood uncommon ( may effect up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge ), numbness or a feeling of heaviness or loosening of a tooth . these could be signs of bone damage in the jaw ( osteone
keep out of the reach and sight of children . do not use zoledronic acid hospira after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zoledronic acid hospira contains - the active substance is zoledron acid . one vial of zoledor acid contains 4 mg zoledrin acid . - the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledic acid hospir looks like and contents of the pack zoledicle acid hospire is a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains one vials of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when cancer treatment chemotherapy is given . chemotherapy destroys nerve cells in the brain , causing vomiting . people who are sick ( sick ) when they are being sick are more likely to get rolapit . these nerve cells help to control nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking varubry if you : have depression or difficulty sleeping ( see section 2 " warnings and risks "). this medicine should not be used 27 if you have severe liver or kidney problems . if you currently take certain medicines containing rifampicin ( used to treat tuberculosis or other
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . you may take it with or just after food . it is best to take the tablet at the same time each day . if you take more varubys than you should if you accidentally take too many tablets , contact your doctor straight away . if possible , take the tablets with you . if sickness occurs , take them as soon
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swellingof skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , as you may need appropriate treatment . other side effects include : very common ( may affects more than 1 in 10 people ): headache , constipation , feeling tired uncommon ( may effect up to1 in
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapitin . - the other ingredients are lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . what varubey looks like and contents of the pack varubry is
what enerzair breezhaler is enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and the active substance glycopYRronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone furyate belongs to agroup of medicines known as corticosteroids or steroids . corticoposteroids reduce the swelling and irritation ( inflammation
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you have : heart problems if you develop an irregular or fast heartbeat if you suffer from thyroid gland problems if your family has diabetes , high blood sugar , seizures if you drink alcohol if you smoke if you know that you have severe kidney problems if any of these
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the medicine should be inhaled by mouth or inhaled through a syringe . you should inhale enerzair breezhaler every day until your asthma is gone . this will help control your symptoms . how to use enerz air breez inhaler use enerzeair breezy inhaler as described in this leaflet . you will find an inhaler and capsules that contain the medicine . the inhaler is for inhalation use only . the capsules should be swallowed whole with water . do not
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side side effects include the following side effects : very commonly ( may affects more than one in 10 users ): sore throat , runny nose , sudden difficulty breathing , feeling of tightness ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used within one month after first opening . do this if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate , 63 microgram of glycopreyronium bromides , 50 microgram glycopyronium and 160 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram indacatedol ( acetate ) and 58 microgram ( 23 microgram ) glycop
clopidogrel acino pharma gmbh contains the active ingredient clopidgin which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thromebosis ). clopidineogrelacino pharmá gmbhs is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atheroth
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopipidogel or any of the other ingredients of clopidineogrel agibutil ( see section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelacino pharmara gmbhl . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines : if
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopidineogrel a day to be taken orally with or without food . you can take clapidogl acino pharma gmb h with or just after food . if you take more clopidoogrel agrogrogroggmbh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . if possible take cl
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : common ( affects 1 to 10 users in 100 ) uncommon ( affects less than 1 user in 1 , 000 ) rare ( affects up to 1 user per 10 , 000 ). very rare ( affect less than1 user in 10 ,000 ). contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . signs of liver problems such as yellowing of the skin and / or the
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplidogl acino pharma gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmá gmb h looks like and contents of the pack clopideogrel acute
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults who are already taking medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine ( ( a nucleosides analogue reverse transcriptases inhibitor ( trti ). the other active substances in delstrigo are tenofovir disoproxil ( a neoside analogue reverse transcriptase inhibitor , nrti ) and tenofavir disostroxil . what del
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if taking any of them : - if you have taken any of a combination of any or all of the following medicines : carbamazepine , oxcarbazepine or phenobarbital , phenytoin ( medicines used to prevent seizure ) rifampicin or rifapentine ( medicines to treat
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for the treatment of hiv infection . the dose is 1 tablet a night . your doctor may prescribe you certain medicines ( such as doravirine ). your doctor will tell you which medicines to take . taking this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . if you take more delstriga than you should if you have taken more tablets than
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea , stomach pain , vomiting wind ( flatulence ) hair loss rash muscle symptoms ( including pain and stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion and suicidal thoughts
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ) the other ingredients are croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumate . a coating material containing carnauba wax e903 , hyproellose , iron oxide yellow ( e172 ), lactose monohydrate , titanium dioxide e
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression . these include feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and a feeling of being slowed down . spravato is used in combination with another antidepressant , which is used every 2 weeks . if you have any further questions on the use of antidepressant medicines , ask your doctor or pharmacist .
do not take spravato - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). - have recently had a heart attack . within 6 weeks of starting treatment , a temporary increase in blood pressure can occur . serious complications in these conditions can occur , and spravo must be stopped . tell your doctor before taking this medicine if you have a heart problem , such as poor blood
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravat nasal spray is a clear , colourless to pale yellow solution . the nasal spray device is available in packs containing 1 , 2 or 3 nasal spray devices . one nasal spray handset is sufficient for 4 doses . if you use more spravatos than you should if you have used more spradato than you have been told to , contact your doctor immediately . if possible , use the nasal pump device at least 4 hours before or 4 hours after taking sp
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected from others , feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch in the mouth area spinning sensation vertigo vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy , euphoria , feeling agitated , feeling anxious , feeling in the eyes , ears , sense of touch are altered or mimicked irritable panic attacks change in perception 37 feeling
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution for use in children . spravata is available in packs containing a single - use nasal spraydevice . spavato is available as packs containing 1 , 2 , 3 or 6 nasal
zerboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . it can only be treated if you have a type of cancer called a change ( mutation ) in a gene called ' melanoma ' that has been changed . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ) symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if you think any of these apply to you , tell your doctor or nurse before using zelberaf . allergic reactions if allergic reactions occur during treatment with zeloraf , tell a doctor or hospital pharmacist immediately if you have any symptoms of an allergic reaction such as swelling ofthe face , lip or tongue ), difficulty breathing or rash and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 capsules taken once a day , with or without food . your doctor may increase your dose to 8 capsules once a week , with 4 capsules once daily , depending on how you respond to the medicine . your dose may be increased or decreased depending on side effects and your response to your treatment . taking zelboraf can be taken with or just after food . if you take more zelberaf than you should if you accidentally take too many capsules , contact your doctor immediately . if
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you notice any of the following symptoms : radiation treatment may cause side effect associated with radiation . zelbaraf treatment may also cause radiation to affect the skin , esophagus , bladder , liver , rectum , and lungs . tell your physician immediately if your doctor notices any of these symptoms : skin rash , blistering , peeling or discoloration of the skin shortness of
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any particles in the pack or if the blister is damaged . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of veMurafenb ). the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide . what zelberaf looks like and contents of the pack zelb
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ) and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood vessels expand . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood cl clots from forming in hardened arteries , a process known as atherostrombotic events , which can lead to stroke
do not use duoplavin - if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ) - if your child is allergic to other products called non - steroidal anti - inflammatory products - if he / she has painful and / or inflammatory conditions of muscles or joints - if his / her child has a medical condition ( such as asthma , nasal discharge , runny nose , polyps or other type of growth in the nose ) - whether your child has had a medicalcondition that is currently causing bleeding such
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , tell your doctor immediately . if possible , take the tablet pack with you . you may need to go to the nearest hospital emergency department to reduce the risk of bleeding . if necessary
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in order to protect from light and moisture . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 tablets of the active substances , clopidogrel and acetylsalicylic acid (asa ). each 75 mg tablet contains clopridogrel ( as hydrogen sulphate ). each 80 mg tablet also contains acetylSalicylicacid , mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil . see section 2 ' duopllin contains hydrogenatedcastor oil ' for further information . the other
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonine tartrate belongs to an active group of medicine called alpha - 2 adrenergic receptor agonists . it works by reducing pressure within the eye . simbrinze is used in the eyes of adult patients ( aged 18 years and older ) to treat eye conditions such as glaucoma , ocular hypertension ( high pressure on the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you cannot take certain antidepressants if you suddenly stop taking any antidepressant medicines if you : have severe kidney problems have too much acidity in your blood ( hyper
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid touching the front of your eye or the front part of your eyes with your hands ( see section 1 , " how to use simbrinusza "). do not touch the cap or snap collar . before using the medicine , twist off the cap . hold the bottle with your fingers . tilt the bottle back . pull down the eyelid with a clean finger and squeeze gently until there is a ' pocket ' between the eyelids and the eye
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ), you must tell your doctor immediately . signs of an allergic reaction include : severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat . tell your heart doctor immediately if you experience extreme tiredness or dizziness . the other side effects that have been reported with simbrinza are : common side effects ( may affect up to 1 in 10 people )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . after first opening , use within 4 months to prevent infections . do away with the bottle once you have opened it and use a new bottle . do this every time you have a new tablet . do you throw away any medicines via wastewater or household waste ? ask your pharmacist how
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of of brimonine tartrate equivalent to 1 . 3 mg of Brimonidine ). - the other ingredients are benzalkonium chloride ( see section 2 " simbrinnza contains benzalkonaium chloride "), propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric acid , sodium hydroxide , purified water
filgrastim ratiopharm contains the active substance filgrastam . filgrasterim is a protein produced by biotechnology in bacteria called escherichia coli . it is similar to a natural protein produced in the body called granulocyte - colony stimulating factor ( g - csf ). filgrasteim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgnastim helps your body to produce more white blood cells quickly . fil grastim riopham is used in adults who have
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrastersim or any of the other ingredients of filgrasteim ratisopharm . warnings and precautions talk to your doctor or pharmacist before using filgrateim ratitopharm : - if your child has a cough , fever or difficulty breathing . this may be a symptom of a pulmonary disorder . tell your doctor straight away if your baby gets any of these side effects . - if the child has sickle cell disease 57 - if he or she gets left upper abdominal pain or pain at the tip of
what filgrastim ratiopharm is and how it works filgrateim ratisopharm will be given to you by a doctor or nurse . you will be asked to take filgrasteim ratiotopharm for one month . how much filgrasterim ratitopharm you will receive filgrasim raticoopharm treatment will be started by your doctor or other health care professional . the usual dose of filgrustim raticopharm given to patients receiving chemotherapy is 0 . 5 mg per kilogram bodyweight . this will be gradually increased to 60 mg per kg bodyweight over
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder . see section 4 . possible side effects . your doctor will carry out regular blood tests before you are given fil grastim ratiopharm . these are to check the number of neutrophils ( a type of white blood cells ) in your blood . your blood will be tested before and during treatment . other medicines and filgrASTim ratisopharm tell your doctor or pharmacist if you
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim piriopham if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasim . each ml of solution for infusion contains 60 mg of filgrateim . filgrasterim ratisopharm 30 mg : each pre - filled syringe contains 0 . 5 ml of fil grastim in 0 . 0 ml solution . filgnastim risopharms 48 mg : one pre - drawn syringe containing 48 mg of filmgrastrim in 0. 8 ml solution , the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol , polysorbate 80 and
what riluzole zentiva is riluxole zenta contains a substance called rilusole which belongs to a group of medicines called antineuropathy . it works by stimulating the nervous system to work normally . what rilizole zENTiva is used for rilustole zertiva is given to adults with amyotrophic lateral sclerosis ( amy ) motor neurone disease ( ms ). ms affects the nerve cells responsible for sending messages to the muscles , causing weakness , muscle waste and paralysis . ms is caused by the destruction of nerve cells . motor neurones disease may also be caused by too
do not take riluzole zentiva - if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before taking this medicine . warnings and precautions talk to your doctor or pharmacist before taking rilzole zenta : - if your doctor has told you that you have any liver disease . - if the doctor has given you increased blood levels of some enzymes of the liver called transaminases . - tell your pharmacist if you think you may be pregnant . warnings , precautions and precautions tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the tablets should be taken by mouth once a week for 12 weeks . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zenta with food . if a child swallows some tablets , contact your physician immediately . do not take a double dose to make up for a forgotten dose . if your child swallips some tablets contact your healthcare
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). during treatment with riluzole zentiva there may be a decrease in the number of white blood cells . your doctor will take a blood sample to check for this . white blood cell counts are important in fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests
what riluzole zentiva contains the active substance is rilusole . the other ingredients are : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). what rilizole zenta looks like and contents of the pack the tablets are white to off - white , round , biconvex , with a diameter of 50 mm . riluxole zENTiva is available in packs containing 202 tablets
emgality contains the active substance galcanezumab . this is a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ), which is involved in migraine . increased levels of cgrm can lead to an increased risk of migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older who have at least 4 migraines per day . emigality can reduce the frequency of migraine headache and improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions serious cardiovascular diseases allergic reactions emg abnorm may cause serious allergic reactions . these reactions may occur up to 40 minutes after you have had a serious allergic reaction . if you notice such signs , tell your doctor straight away . you may be more at risk of side effects as described in section 4 . children and adolescents emgally is not recommended for children and teenagers under the age of 18 years . other medicines and emgals
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg / m2 body surface area . emgally will be injected under your skin ( subcutaneous injection ). you will receive your emgalis injection with proper training . if you use more emgals than you should if you have used more emgsality than you have been told to , contact your doctor immediately . if more emmality than your doctor tells you to use , contact a doctor or go to the nearest hospital immediately . do not use a double dose
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , use within 7 days or store below 30 . do this medicine if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . - the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is slightly yellow . the syringe is provided in a pack of one single - dose pen . pack sizes of 1 , 2 , 3
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hepatic vesicin ) in which the blood vessels in the liver become damaged and blood clots form . it may be given to you if you have not previously received medicines prior to a stem cell transplantation . defibrorotide works by helping the blood arteries to open and close , so that the blood clasts can be removed . if you are given more defitelios than you should if you think you have been given too much
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions talk to your doctor or nurse before using this medicine if you : have bleeding , especially heavy bleeding if you need a blood transfusion or surgery if you suffer from problems with blood circulation ( a constant blood pressure ) if any of these apply to you ( or you are not sure ), talk to the doctor or pharmacist before using defitELio . children and
the treatment with defitelio will be started by a doctor who is experienced in the treatment of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . the duration of this treatment is 21 days . if you have any further questions on the use of this medicine , ask your doctor or nurse . if more than 18 days have passed since you received your dose of defitelo , tell your doctor , nurse or pharmacist . if possible , take the next dose at the usual time . do not take a double dose to make up for a
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding including the nose bleeding from the brain bleeding from inside the gut vomiting blood bleeding from around the lungs bleeding from blood in the urine and in the mouth bleeding from under the skin coagulopathy ( disturbance of blood clotting ) nausea vomiting diarrhoea rash itching fever uncommon (
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do do not defiteloio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of solution contains 2 . 5 mg or 200 mg of defibrorotide ( as besilate ). each ml solution contains 80 mg of the active ingredient in defibriide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections ( see section 2 " defitelsio contains sodium "). what defitELio looks like and contents of the pack defiteloio is a clear , colourless to pale yellow concentrate for solution for
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . it also prevents the virus from spreading to other parts of your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be taking with daklineza are : - combination with daclatinza with other treatments to treat the hepatitis k infection . your doctor will discuss with you which combination of the other treatments is best for you
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with or without food . if you have taken any of these medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to treat tuberculosis ) dexamethasone ( a steroid used to correct allergic and inflammatory diseases ) medicines containing st
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this dose once a week . do this to avoid unpleasant taste . your doctor may tell you to take dakinza with some other medicines . how much to take take dailinza with food and drink you should take daclinza at the same time each day . you should continue taking these medicines until your doctor tells you otherwise . your daily dose of taklinz should be taken at
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is used in combination with sofosbuvir and ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when dailinza in combination of sofosebuvir or ribavir the following other side effects are reported : common ( likely to affect up in every
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide , macrogol 400 , indigo carmine aluminum lake ( e132 ) and yellow iron oxide ( e172 ). what daklineza looks like and contents of the pack 30
proquad is a vaccine that protects against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the measles , rubles , rubell and varicelluses . the antibodies help to prevent diseases caused by these viruses . proquad is given to adults and adolescents from 9 years of age and older . it is given in combination with national vaccination squeds containing measles , live viruses containing measles ( mumps ), rubella , chickenpox or varicello . the vaccine is given at
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have been given neomycin if you suffer from a blood disorder or type of cancer that affects the immune system , treatment with medications that weaken the immunesystem ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ) if your child has a weakened immune system due to a disease ( including aids ) if he / she has congenital or hereditary immunodeficiency ( immune competence )
proquad is given by injection into the muscle or under the skin ( usually in the thigh or upper arm ). injections will be given into the upper muscle ( usually the thigh area ) or into the lower arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . bleeding may occur after injection into a muscle . proquad is injected into a blood vessel . prorant is given as an injection into an area of the skin that protects against bleeding ( usually into the back of the muscle ). proquad will not be injected into an empty blood vessel ( see section 2
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side side effects reported with the use of proquad are : very common ( may affects more than
what proquad contains the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , 4 . 30 mg rubella virus2 , strain , equivalent to 3 .00 mg varicella virus3 , merck strain , strain 3 . 99 mg mrc . the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 what proquad looks like and contents of
jylamvo is a substance that is absorbed by the body and is an anticancer medicine that reduces unwanted reactions . it is an immunosuppressive agent . it acts on the body ' s own immune system to reduce its inflammatory activity . jylamv is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( i . e ., polyarthritic forms of the joints ) in adults and adolescents with severe juvenile idiopathic arthritis ( jia ) in children and adolescents ( 3 years of age and older ) who have not previously used non - steroidal anti - inflammatory drugs (
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 if you know that you may have a weakened immune system if you think you have or have ever had a serious infection such as tuberculosis or hiv if you develop ulcers in the stomach or intestines ( an inflammation of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will determine the most appropriate dose for you and will adjust the dose depending on your response to the treatment . rheumatoid arthritis severe juvenile idiopathic arthritis severe psoriasis severe psoriatic arthritis jylimvo is used as a long - term treatment . jrylamvo is also used for rheumatic and skin diseases such as jia , psorism or psoriatics . your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching affecting your whole body . these side effects may be serious and need immediate medical attention . breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising , nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the medicine should be used immediately after dilution . in case of accidental spillage , the product should be disposed of within 3 hours . do away with any unused medicine or waste material . these measures will help protect the environment . cytotoxic products are not to be used in children .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotexate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydrobenzoates "). what jyamelvo looks like and contents of the
what enurev breezhaler is this medicine contains the active substance glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what enurevo breez inhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if there is an eye problem called narrow - angle glaucoma ( difficulty passing urine ). if this applies to you , tell your doctor . treatment with enurevi breez inhaler should be stopped immediately . if you experience tightness of the chest , coughing , wheezing , breathlessness , stop using enurevo breezer and seek medical help
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at a temperature of 75 to 75 ºc . you can use this medication at any time of the day , with or without food . this medicine is for inhalation use only . you must use this when you are using an inhaler and capsules ( in blisters ). the medicine is inhaled using inhalation powder . the capsules should be swallowed whole with water . do not crush , chew or break
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst , hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness . allergic reaction ( swelling mainly of the tongue , lips , face or throat ) angioedema ( see section 2 ). if any of the side effects gets serious , or if you notice any of these side effects not listed in this leaflet , please
what enurev breezhaler contains the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycoprroniumbromide equivalent to 50 microgram glycopyronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopYRronium per inhalation dose . the other ingredients are lactose monohydrate and magnesium stearate . what enurelv breez inhaler looks like and contents of the pack enurevo breezer 44 microlitre inhalation powder is a white
what riximyo is riximusimyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type called a white blood cell called " b - lymphocyte ". when ritiximab sticks to the target of this target , it stops the cell from growing and dividing . what rixima is used for rixinemyo is used to treat adults with the following conditions : - non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue . the immune system
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangitis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using rixi . rixibyo
your doctor will decide how much riximyo you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . if you have any side effects , your doctor may lower your dose . riximusyo is given as a drip ( intra - venous infusion ). medicines given before each riximeyo administration you will be given rixiu with other medicines ( premedication ) to reduce the risk of side effects . your doctor will also tell you how long you should continue your treatment . for non - hodg
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing or palpitations , heart attack , low number
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg of the active ingredient ( ritiximab ) ( 10mg / ml ) the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide , hydrochloric acid ( see section 2 " rixima contains sodium "). what rixamyo looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion .
topotecan actavis contains the active substance topotecin . topotecaan activ is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotican actv treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using topotocan activ . your doctor will check your blood cell counts and may decide if they are too low . do not use more topotican actez than your doctor has recommended . - if your doctor thinks you have any kidney problems . warnings and risks talk to the doctor , nurse or pharmacist before using this medicine . topotcan actrix should not be used
your doctor will determine the dose of topotecan actavis you will receive based on the severity of the disease and on results of blood tests carried out before treatment . the usual dose for treatment of adults small cell lung cancer is 1 . 5 mg per square metre of body surface area for every 5 square metres of body weight . this treatment cycle will be repeated every three weeks . for cervical cancer , the usual starting dose is 0 . 75 mg per sq metre of surface area once every 3 weeks . this dose cycle will also be repeated each three weeks for cervical cancers . when used with another anticancer medicines , the dose may be
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . this may be a sign of your general condition . local symptoms such as sore throat or burning sensation , severe stomach pain , fever , diarrhoea , or bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , may effect up to 1 in 1 , 000 people ): difficulty in breathing ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 ± 2 and from 2 to 8 when stored in a refrigerator ( 2 to 9 ). the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) and glucose 5
what topotecan actavis contains - the active substance is topotecaan . each vial contains 1 mg or 4 mg topotan ( as hydrochloride ). after reconstitution 1 ml contains 1mg topotican . - the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotnican actis looks like and contents of the pack topottecan acti is a white to off - white cake with grey bromobutylic stopper and aluminium seals with plastic flip - off caps and a protective
the active substance of rivastigmine hexal is rivostigmine . rivustigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivasterigmine works by blocking the enzymes that break down acetylchloroline : acetylchelinesterases and butyrylcholinescerase . by
do not take rivastigmine hexal - if you are allergic to rivasta ( the active substance in rivostigminehexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - if a previous skin reaction ( allergic contact dermatitis ) has been severe . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have irregular or slow heartbeat . - you have an active stomach ulcer . - tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , your doctor may increase your dose to the highest dose of 6 . 0 mg per day . your doctor can also change your dose depending on your weight . your physician will tell whether you should take this medication or not . if you have not taken rivasta hexal for more than three days , do not take the
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below are very common ( may affect more than 1 in 10 people ). feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may affects up to1 in 100 people
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastsigminehexal 1 . 5 mg capsule contains 1 . 25 mg of rivostigmine . each vial of each ritastigmin hexal 3 mg capsule releases 3 mg of the active ingredient in each riastig
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat kidney cancer , renal cell carcinoma or liver cancer in adults who have previously received a specific anticancer medicine containing sorafenib . how cabometyx works cabometx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking these proteins , cabometometyx can kill high amounts in cancer cells . if you have any questions about how caboyyx works or why this medicine has been prescribed for you , ask
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety if you have high blood pressure , have had an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall , have diarrhoea , have recently had significant bleeding from surgery within the last month , have undergone surgical procedures , dental surgery , have inflammatory bowel disease , crohn ' s disease , ulcerative colitis , diverticul
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take this tablet at the same time each day . your doctor may increase your dose depending on how you respond to your treatment . this will help reduce the risk of serious side effects . your treatment with cabometyx will usually last for 60 days . you will usually start taking cabometometyx at least 2 hours before your next meal . you may take cabometx for 1 hour before your first meal . swallow the tablet whole with a glass of water
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor or nurse straight away if your side effects become severe or uncontrollable . these side effects can be serious and require urgent medical treatment : symptoms include pain in the abdomen ( nausea ), vomiting , constipation and fever . these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or unpredictable bleeding . symptoms include vomiting blood , black stolls , bloody urine , headache , coughing up blood , swelling , pain in your hands
what cabometyx contains the active substance is cabozantinib ( s )- malate . cabometx 20 mg tablets : each tablet contains cabozatinib / malate , equivalent to 20 mg cabozorinib . cabobometyx 40 mg tablets tablet contains cabozanthinib ( ss ) - malate, equivalent to 40 mg caboxantininib ). cabometometyx 60 mg tablets tablets tablet contain cabozutinib - malates , equivalent of 60 mg cab ozantinil . the other ingredients are : tablet core : microcrystalline cellulose
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira in combination with cisplatin , another anti - cancer medicine , is used for treatment of malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , when patients have not received prior chemotherapy . pemrexedospira in addition to cisplin is used in patients who have had the initial treatment for lung cancer . your doctor will determine whether pemetrixed hospir is suitable for you if you have lung cancer at an advanced stage if your disease has responded to
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospir : - if any of these apply to you , tell your doctor before using it . - you have or have had problems with your kidneys . before you receive pemet
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . your doctor will use this body surface area to work in exactly the right way . frequency of treatment will depend on your blood cell counts and on your general condition . the doctor will have mixed the pemetreed hospir powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . pemetresed hospire will be given to your doctor by infusion into one of your veins
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ): if you have a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you get chest pain ( common ) or a fast heart rate ( uncommon ). if you develop pain , redness , swelling or sores in your mouth ( very common ) allergic reaction : if you notice skin rash , burning or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . chemical and physical in - use stability of reconstitution and infusion solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature . the reconstuted solution should be administered immediately after preparation . parenteral medicines : if you notice discolouration
what pemetrexed hospira contains the active substance is pemetreed . pemetrixed hospiras 100 mg : each vial contains 100 mg of pemetereed ( as pemetretrexed disodium hemipentahydrate ). pemetoxed hospiry 500 mg : one vial provides 500 mg of dispemetrexED ( as dispemetreted dis sodium hemipertahydrates ). pemrexedospira 1 , 000 mg : the active ingredient is pemphigus . each vials provides 1 , 500 mg pemetretted (as pemet
what ganfort is ganant contains two active substances called bimatoprost and timolol which work together to reduce pressure in the eye . bimatraoprost belongs to a group of medicines called prostamides , which work by blocking a prostaglandin analogue called timolole . timololine belongs to medicines called beta - blockers . what ganatoprist looks like and contents of the pack ganit is a clear , watery liquid that is injected into the eye by your eye . it is used in adults , adolescents and children aged one year and above . the eye is the
do not use ganfort eye drops if you are allergic to bimatoprost , timolol or beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) if you have respiratory problems such as asthma or severe chronic obstructive bronchitis if you suffer from severe lung disease ( signs include wheeziness , difficulty in breathing , and long - standing cough ) if any of these apply to you , tell your doctor before using ganf . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have coronary heart disease ( symptoms include chest pain , tight
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to use treatment use the bottle and the mirror before using it . - twist the bottle neck 5 . 1 . wash your hands . do not touch your head . 2 . pull down your eyelid , which is covered by a small pocket . 3 . gently squeeze the bottle . gently pull down the front of your eye until it is completely closed . during treatment , 4 . gently press down on the lid of your front eye ( picture 2 ). gently squeeze your eye with a finger until it feels like
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause them . most side effects are mild to moderate and are usually mild to short - term . if you notice any of the following side effects after taking ganart ( multi - dose or single - dose ) you should contact your doctor immediately : very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging or irritation of the conjunctiva ( the transparent layer at the back of
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with ganfolds if you notice that the solution is discoloured or contains particles . do this to prevent eye infections or if it is discolorated or contains visible particles . ganFort is for single use only . do throw away any medicines via wastewater or household waste . ask your pharmacist how to
what ganfort contains - the active substance is bimatoprost . each ml contains 0 . 3 mg timolol ( equivalent to 5 mg timlol maleate ). each vial contains 6 . 8 mg of bimataoprost ( as benzalkonium chloride , a preservative ). - the other ingredients are sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly yellow , colourless to
gefitinib mylan contains the active substance gefitinib . this protein is designed to kill cancer cells . gefitoninib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefitalinib melan if : you have any other lung problems . some lung problems may be serious . gefinib yourlan should not be used if you have problems with your liver . gifitin ib mylan should be used in children and adolescents under 18 years of age . other medicines and gefnitinib tell your doctor or pharmacist if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 250 mg tablet once a day . you can take antacids on an empty stomach ( see section 2 , " gefitinib mylan contains lactose "). take the tablet at least 1 hour before or 2 hours after food . gefnitinib melan is for oral use . swallow the tablet whole with a glass of water . if you have trouble swallowing the tablet , you can crush it and mix it with any other liquids . the total recommended dose for
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommonly ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions affecting parts of the body .
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - in the tablet coating are polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan looks like
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms can include a low red blood cell count and anaemia . red blood infusion is usually given to patients with mds who cannot receive red bloodcell transfusions . reblozey is used in adults to treat anaemia ( md ) caused by lack of red blood blood cell transfusions in patients who cannot be treated with erythropoietin therapies
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor before taking this medicine if you have thalassaemia ( a condition where the spleen removed ) or have had a blood clot . your doctor may recommend hormone replacement therapy if you had a previous blood clot and you are taking preventive measures ( including medicines to prevent a blood clot ). if you suffer from high blood pressure , your doctor will decide whether rebluzyl is
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . reblzyl is given as an injection under the skin . the injections should be given every two weeks . the usual dose is 1 . 0 mg / kg of body weight . your dose may be adjusted by your doctor depending on your blood pressure . use in children and adolescents rebl ozyl is used in the treatment of myelodysplastic syndromes . the maximum single dose is given to children of 1
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , blurred vision , which may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , including rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 hours or at room temperatures up to 24 hours ( below 2 ). do away with any unused medicinal product or waste material . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspormcept . after reconstitution , each ml contains 50 mg of the active ingredient luspaterscept . the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct and ph adjustment ). what rebl ozyl looks like and contents of the pack reblizyl is a white to off - white powder . reblosyl is supplied in v
fotivda contains the active substance tivozanib , a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer . it stops the growth and spread of cancer cells by blocking new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking fotiveda if any of these apply to you . high blood pressure the dose of fotiva depends on your blood pressure . your doctor will check your blood blood pressure regularly while you are taking a medicine . fotivoda may lower your bloodpressure if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg once a day ( 21 capsules ) taken in the morning and evening . this means that you take 7 capsules in the evening and 7 capsules at the evening . the total daily dose is 4 capsules in a row . if you take more fotvda than you should if you have taken too many capsules , you may experience unacceptable side effects . severe side effects may occur during fotivada therapy . the maximum daily dose of the fotive
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( this side effect can occur in more than 1 in 10 people ) tell your doctor immediately if you experience any of the following : high bloodpressure with symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high blood blood pressure may be increased when you start taking a medicine to treat your high blood Pressure . if you take more
what fotivda contains the active substance of fotive is tivozanib . each tablet contains 890 mg of tivuzanib ( as tiv ozanib hydrochloride monohydrate ). the other ingredients are : tablet core : 890mg tivzanib , mannitol ( e421 ), magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( e1520 ) and strong ammonia solution ( e524 ). tablet coating : titanium dioxide , tartrazine aluminium lake (
stribild contains two active substances : elvitegravir , an antiretroviral medicine called an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of elvitesgravira emtricitabine , an antiviral medicine known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil , an antipirtrovir medicine known also as aucleotide reverse transcriptases inhibitor ( rtrti ). stribild is given as a single tablet regimen for the treatment of human immunodef
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofoviir disopicroxil . your doctor will monitor your kidney function and may change your dose of these medicines . if you have been told by your doctor that you have alfuzosin ( an enlarged prostate gland ), amiodarone , quinidine ( used to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age : take the tablet 35 once daily by mouth . you should continue to take your medicine at the same time each day . your doctor may change the dose or stop the treatment if you take medicines ( oral supplements , antacids , laxatives containing minerals , magnesium , aluminium , calcium , iron , zinc ). take the tablets at least 4 hours before or 4 hours after taking stribild . if you have any further questions on the use of st
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects of stribild are caused by the hiva disease itself or by the way stribil works . serious side effects tell your doctor immediately if you experience any of the following :
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtritabine , 245 mg tenofovegravor disoprocessil and 300 mg ten ofovir dissoproxel fumarate . each tablet contains 136 mg tenorovir . the other ingredients are croscarmellose sodium , hydroxypropyl cellulose , lact
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zyPrexa . zypitxa is not recommended for elderly patients with dementia because it may have serious side effects .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken once a day . your doctor may increase your dose to one 5 mg tablet once a week or to one 20 mg tablet twice a day depending on your symptoms . swallow the tablet whole with a glass of water . you can take zypxa with or without food . you should take your zypitxa tablets at the same time each day . you may take your tablets with or just after food . zzyprexa coated tablets are for oral use . swallow
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( a rare side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . zyprexa does not require any special storage conditions . do this if you notice that the pack is damaged or shows signs of tampering . do ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zypxa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg . the other ingredients are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are : - zy prexa 2 . 0 mg , 10mg , 7 . 0mg , and 10 mg - shell
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein found naturally in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment with prolia has failed . prolia helps to make bone stronger by reducing the amount of oestrogen produced by the bone . this helps to prevent bones from becoming thin and fragile . what osteopORosis is osteoporeosis is caused by the lack of enough of the female sex hormone testosterone . when osteopoorosis is not treated with testosterone or glucocort
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think you may have a skin infection , symptoms include a swollen , red area of skin in one leg that feels hot , tender or if there is cellulitis ( symptoms include fever ). if any of these symptoms indicate an allergy to latex , please remove the needle from the pre - filled syringe and use a derivative of latex .
what prolia is prolia contains one pre - filled syringe of 60 ml . it is given every 6 weeks as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . prolia can be used with or without stickers . you may also receive a single injections under theskin ( subcoveraneous ) ( in the thighs or abdomen ) or in the upper arm ( subtype ). how prolia works prolia comes in different colourless glass vials . you can use prolia with or with stickers . your doctor will tell you how much prolia you need . how
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and tell your doctor straight away if you develop skin infections ( cellulitis ). if you experience any of these symptoms while taking prolium : swollen , red area of skin , usually in the leg , which feels hot and tender . symptoms may include fever . stop using prolia if you have pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), as these could be signs of bone damage in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . keep the vial in the outer carton in order to protect from light . before you use your pre - filled syringe , it should be used within 25 days after the injection . however , it may be stored at room temperature ( up to 25 ) for a maximum period of 30 days . do this as long as the solution is clear and colourless . do do not throw away any medicines via
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab ( 60 mg / ml ). - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirux is a vaccine for adults and adolescents from 1 to 15 years of age . it is used to treat two diseases : hepatitis a and hepatitis b : infection with the hepatitis a virus , which causes the liver to become swollen and inflamed . the virus can also infect faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . you may feel sick , have a fever , aches and pains , feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to
do not use ambirix if you are allergic to ambirux or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine . if any of these apply to you , tell your doctor or nurse straight away . warnings and precautions talk to your doctor , nurse or pharmacist before using ambirx if you : have ever had hepatitis a or hepatitis b diseases . have a severe infection with a high temperature . the vaccine should be given at the same
your doctor or nurse will give you ambirix as an injection into a muscle in the upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . if you miss an injection , the second injection should be given between 6 and 12 months after the first . if it is more than 12 months since the first injection , you may be given extra doses to make up for future booster dosing . if more than two injections are given at once , you will be told to stop using ambir
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : very common ( may affect more than 1 in 10 people ): headache loss of appetite feeling tired irritable pain or redness where
what ambirix contains 26 the active substances are hepatitis a virus ( 1 , 720 micrograms / ml ) and elisa units ( hepatitis b surface antigen ). the other ingredients are 20 microgram per ml , human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a white , slightly milky liquid . ambarix
what bexsero is bex serumo is a meningococcal group b vaccine . what bex sero is used for bex Sero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria cause infections ( such as meningitis and inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your immune system ( the body ' s natural defences ) to fight the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using bex serumo if : you have a severe infection with a high temperature ( over 38 ). vaccination should be postponed until you have recovered from a minor infection such as a cold . your doctor may decide to delay vaccination if you have haemophilia a or any other problem that may prevent your blood from clotting properly . you are using blood thinners ( anticoagulants ) as part of treatment for your immune system ( eculiz
your doctor or nurse will give you bexsero at a dose of 5 micrograms per injection into the muscle of the thigh or upper arm . injections will be given at least 2 weeks apart . if you are given more than 5 micrograms , you will receive three injections of the vaccine . your doctor will give an additional injection ( booster ) at the interval between injections . the interval from injections will last approximately 1 month . if the intervalbetween injections is longer than 2 months , your doctor may give you a booster . children and adolescents from 12 to 15 years of age from 6 months of age , the doctor will administer
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site and hardness of the area of skin at site of the injection . other side effects may occur with this vaccine . common ( might affect up to 1 in every 10 people ) fever , loss of appetite , tenderness around the injection area
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 and 50 micrograms recombinant nisseria maningitis group b noada protein 1 and 2 , 2 and 3 50 microgna recombinant neurisseria meingititidis ( group b fhbp fusion protein ) 1 , 3 , and 50 micromegna recombinating neissia meningitsidis group a fhba protein 1, 2 , and 3 , 50 microgamgna is produced by recombinant dna technology .
nitisinone mdk contains the active substance nitisinon . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hty ) in adults , adolescents and children from 1 year of age . in this disease your body does not produce enough of the amino acid tyrosine ( amino acids are substances that are important in building our body ). nitisinnone helps to reduce the amount of tyrosinine and the harmful substances that can be produced . this means that your body can eliminate tyrosrine from your body . by replacing low tyrosines with phenylalanine ( another amino
do not take nitisinone - if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone mdk may affect your eyes . during nitisinfone treatment , red eyes may occur . if you notice any of these effects , tell your doctor immediately . your doctor may recommend an eye examination . if any of this applies to you , tell the doctor . eye problems due to inadequate dietary control ( see section 4 ) your doctor will monitor the treatment closely
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once daily . the dose may be increased to 20 capsules once daily in this patient population . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact your doctor immediately . if
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , use within 2 hours at a temperature not above 25 . do away with the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nitisinone mdk contains the active substance is nitisino . nitisinnone mdks 2 mg : each capsule contains 2 mg nitisine . nitesinone dk 5 mg : one capsule contains 5 mg nisinone . nisinnone dsk 10 mg : two capsules contain 10 mg nitesine . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitisinsone mdK looks like and contents of the pack nitisinfone mdky capsules are 15 . 7 mm long , hard gelatin capsules
docetaxel accord contains the active substance docetaxal . docetxel belongs to the group of anti - cancer medicines called taxoids . docel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer . in the treatment for advanced breast cancer the two active substances are docetixel and doxorubicin , or trastuzumab , or capecitabine . in adult patients with early breast cancer with or without lymph node involvement , docetail
do not take docetaxel accord if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) if you have a low number of white blood cells if you suffer from a severe liver disease . warnings and precautions before taking docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docet . if you experience white blood cell disturbances , such as fever and infections , tell your doctor immediately . if abdominal pain , tenderness , diarrhoea , rectal haemor
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine the dose you should receive . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your blood tests will be taken at regular intervals to check your generalcondition . docetAXel accord may be given
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docel accord may be increased when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions may occur ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp expiry day refers to the last day of that month . store below 25 . do away with the vial and keep it in the outer carton . after dilution , the medicine should be transferred from the infusion bag to the infusion vial 6 hours after it was prepared and stored at room temperature ( 25 ). for infusion , the infusion solution should be used immediately . non - pvc bags 48 hours after dilition are stored at 2 to
what docetaxel accord contains - the active substance is docetxel . each ml of concentrate for solution for infusion contains 20 mg docetel . 1 ml of the concentrate contains 20mg docetixel . 4 ml of solution for injection contains 80 mg docel . 8 ml of solvent for solution contains 160 mg docnetaxel . - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetacord contains ethanol "), citric acid anhydrated ( see " docel accord contain ethanol "). what docetAXel accord looks like and contents of
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . this medicinal product stops the brain from working normally , allowing it to produce its own signals which are important for learning and to react normally . this means that intuniv helps to control your actions and actions . what intunv is used for intunitiv is used to treat impulsive and hyperactive adults . this is also called ' attention deficit hyperactivity disorder ' in adults with adhd who are not taking current stimulant medication . intunipt is used in adults whose current
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking intunive if you have low or high blood pressure . if you suffer from heart problems . if any of these apply to you , tell your doctor before taking this medicine . warnings and risks talk to you doctor or nurse before taking the medicine if you : have heart problems have ever fainted recently have thoughts or feelings of suicide have any other psychiatric conditions or withdrawal symptoms have increased heart rate have high bloodpressure . if this
your treatment will be started by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be gradually increased depending on how you respond to treatment . the starting dose is 0 . 05 mg / kg bodyweight once daily ( for example , 0 . 12 mg / m2 bodyweight ). your dose may be gradually reduced to 1 tablet twice daily ( every 7 days ). your doctor may increase
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , you should stop your medicine and contact your doctor straight away . serious side effects tell your doctor immediately if you notice any of the following serious side side effects : feeling drowsy ( feeling dizzy ), hypotension ( slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect with high blood pressure . symptoms include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these side effects occur , stop treatment
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within the first week of opening the blister pack . do this if you notice any change in the appearance of the tablets . do away with the tablets if you see any change to the appearance or appearance of them . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine . each extended - release dose contains 2 mg of Guanfacin . each long - release treatment contains 3 mg of the active substances guanfuine and 3 mg guanjuine . the prolonged -release dose contains 4 mg of each prolonged prolonged - released dose of guinfacine . see section 4 for further information on guanfa . the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer ,
ecalta contains the active substance anidulafungin and is used in adults ( from 1 to 18 years old ) to treat fungal infection of the blood or other internal organs ( invasive candidiasis ). the infection is caused by fungal cells called candida that are cut off by the body ' s own immune system ( echinocandins ). these medicines prevent serious fungal infections from spreading and destroy fungal cell walls . ecalta works by reducing the number of fungalcells . this will make incomplete or defective cell walls , which may make them fragile and unable to grow .
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using ecaltra if you have liver function problems . your doctor may decide to delay your treatment with anaesthetics or interrupt your treatment . if you think you may have an allergic reaction , e . g . itching , wheezing , blotchy skin , you should tell your doctor immediately . if this happens , you may experience an infusion related
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . the dose is 1 dose in the morning and 1 dose after the evening . adults ( 18 years of age and older ) the recommended starting dose is 3 . 0 mg / 200 mg given twice a week , followed by 1 . 5 mg /100 mg given three times a week depending on the patient ' s weight . ecalta is given as slow infusion ( a drip into a vein ) lasting 1 . 4 to 3 hours . the loading dose will be adjusted by your doctor depending on how well
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects such as convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezed , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia ), diarrhoea ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 . if the infusion solution is not used promptly , in use immediately , it may be stored at 25 for up
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidulinafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltta is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( human cogulation factor iii ). factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is missing or not working properly . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haremophilia b , an inherited bleeding disorder caused by lack of factor v ii .
do not use adynovi - if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is allergic to adynov . warnings and precautions talk to your doctor or pharmacist before using adyno : - if the child has an anaphylactic reaction ( a severe , sudden allergic reaction ) to adnovi . allergic reactions may include rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness
treatment with adynovi will be started by a doctor with experience in the treatment of haemophilia . adynov is used for treatment of bleeding . your doctor will decide whether adynova is suitable for you . the replacement therapy with adnovi is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . prevention of bleeding the recommended dose of adynoc 40 mg / kg or 50 mg /kg is one injection once every 2 weeks . prevention and treatment of blood and bleeding the dose of adsynovi depends on your body weight
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur after the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment is immediately available . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies ( see
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a single period of up to 3 months . do this medicine if it has been stored at a temperature not above 30 for a longer period than 3 months , or if it is stored
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu of ruricoctocag alfa pepegol . the solvent vial provides 5 ml of sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane , polys
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection ). they are involved mainly in the development of the ovaries and in the production of many egg sacs .
do not use this medicine if any of the following apply to you . if you are not sure , talk to your doctor or pharmacist before using rekovelle . warnings and precautions talk to the doctor or nurse before using this medicine : if you have : 6 tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus , enlarged ovaries or cysts on your ovaries ( polycystic ovarian disease ), bleeding from the vagina ( an early menopause ), malformations of the sexual organs ( which may make a pregnancy impossible ), fibroids of the uterus ( which can make a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you at the start of your first treatment cycle . your doctor will tell you how much anti - Müllerian hormone you need to take to stimulate your ovaries to produce more hormones and stimulation with gonadotropins . the amount of hormones in your blood will be calculated based on your body weight . your physician will ask you to take a blood sample during the last 12 months to check how well the medicine is working for you . how much rekole
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported in women receiving this medicine . there may be a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen . nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you experience any of these symptoms , seek medical advice immediately . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation syndrome ) pelvic pain and discomfort ( ovarian
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the vial in the original package in order to protect from light . after reconstitution , the solution may be stored at room temperature ( up to 25 ) for a maximum of 3 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of of follnitropin delta in each millilitere of solution ( corresponding to 0 . 35 mg / ml ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water for
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revisty elliptoe contains flutic asone fureate and 92 mg vilancerol . the 22 mg / 22 mg inhalation contains flitantasonefuroate 184 mg vilterol and 22 mg vincterol ( 22 mg ). what revintchy ellipta is used for revintey ellipta has been prescribed for adults and adolescents 12 years of age and older who weigh at least 184 kg and whose asthma is not controlled with 184 mg / 23 mg
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking revintchy ellipta . if you have liver disease , tell your doctor straight away if you notice any of these side effects . if your doctor determines that you have moderate or severe liver disease . the lower strength of revintty ellipta 92 / 22 mg tablets should be used instead of the usual strength . if any of your medical conditions apply to you , tell
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhalant each day ) with fluticasone furoate and 22 mg vilanterol . for copd the recommended starting dose for adults is one inhale twice a morning ( one tablet each day ). for severe asthma , the higher strength inhaler is fluticusone firoate and the 22 mg dose is vilancerol . copd : the recommended maintenance dose for copdi
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , especially of the face or mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ). immediate breathing difficulties immediate breathing problems stop taking revinty ellipta and contact a
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 microlitres ( the doses leaving the body ). each 92 micrometre inhalation delivers a delivered dosage ( the amount leaving the earpiece ) between flutic asone firoate and 22 microlitre vilancerol and trifenatate . the other ingredients are lactose monohydrate ( see section 2 " revintchy ellipta is sodium "), magnesium stearate .
atripla contains three active substances used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ), tenofovir , aucleotide reverse transcriptatase inhibitor . these active substances are used in combination with antiretroviral medicines to reverse the action of an enzyme ( reverse transcriptased ) that the virus needs to reproduce itself . atripla is a treatment for human immunosuppression
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects ( such as dizziness and drowsiness ) have been reported in patients taking atripola . if you take more atriplea than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablets with you . atriapla can be taken with e
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately :
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripera film - coated tablet contains 600 mg eflavirenz and 200 mg emtrixitabin and 245 mg tenofoviir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atriplea contains sodium "). the tablet film coating
orgalutran contains the active substance ganirelix . it belongs to a group of medicines known as anti - gonadotrophin - releasing hormone ( gnrh ). gonadodotrophins are proteins that are produced naturally in the body . gnrh regulates the release of gonadotroprophins and follicle stimulating hormone ( fsh ). gonadsotrophines play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells from the sacs and give them to your partner . they
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ) or any other gonadotropin - releasing hormone , such as a gnrh analogue . - if your child has a moderate or severe kidney or liver disease . - you are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions may be signs of an active allergic condition . your doctor will perform additional monitoring during treatment . allergic reactions if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is intended for use in women who are undergoing the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), corifollitropin on day 2 or day 3 of each cycle . orgdalutran should be injected under the skin ( subcutaneously ) every 5 to 6 weeks . orgallutran can be used either alone or in combination with fsh . the preparations are for use
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a side effect , tell your doctor immediately . very common ( may affect more than 1 in 10 people ) local skin reactions ( including redness and swelling ). the local reaction usually disappears after about 4 weeks . uncommon ( may affects up to 1 in 100 people ) headache nausea ( malaise ) very rare ( may affecting up to one in 10 , 000 people ) allergic reactions rash facial swelling difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat that may cause difficulty in breathing or swallowing
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be clear , particle - free solutions . do away with any unused syringe . do this if you notice any particles in the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( for the ph ) and sodium hydroxide ( for acetic acids ). what orgaluitran looks like and contents of the pack orgalUTran is a clear , colourless aqueous solution . the solution is clear and colourless . it is supplied in a glass vial for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgalustran is available in
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a type in white blood cell called " b - lymphocyte ". when ritukimab sticks to this target , the cell dies . what blitzima used for blitzima can be used in adults with : a ) non - hodgkin ' s lymphoma this is usually a disease of the lymph tissue . the immune system attacks a type a of white blood cells called b - cells . blitzima may be used alone or
do not use blitzima if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor or pharmacist before using blitzima : if you currently have granulomatosis , polyangiitis , microscopic polyangiaitis or pemphigus vulgaris . if any of these apply
how blitzima is given your doctor will decide how much blitzima you will receive and for how long . this treatment will be given to you by a doctor or nurse who is experienced in the use of this medicine . they will check you for any side effects . how blitzima will be administered blitzima comes as a drip ( intravenous infusion ). you will be treated with medicines given before each blitzima administration . you will also be given blitzima in combination with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . for non - hodgkin ' s lymphoma if you are given blitz
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing or palpitations , heart attack , low number of plate
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml solution . each 50 ml vials contains 500 mg of the active ingredient ritiximab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 glass vials containing 50 ml . pack size of 1 vial .
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain called interleukin - 6 ( interlekin - 7 ). interleukoencephalopathy ( jcb ) is a protein that is involved in causing the inflammation in your body . roactemrea can cause symptoms such as pain and swelling in your joints . roactoremra slows the damage to the cartilage and bone in your bones caused by the disease . roacticemra is used to treat moderate to severe active
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactemnra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips and skin rash . during and after the infusion , tell your doctor if you develop any signs of infection . infections tell your physician immediately if you feel unwell . roactema may cause your body ' s ability to fight infections . tell your
your doctor or nurse will give you roactemra by infusion into a vein ( intravenous infusion ). your doctor or a nurse will supervise the intravenous infusion and will decide on the treatment you need . the recommended dose of roacterera is 8 mg per kg body weight . this dose is given every 4 weeks . the usual dose of 8 mg is 8mg per kg of body weight given once a week . the dose of 30 mg per kilogram body weight is given once every 8 weeks . your doctor will decide the dose that is right for you . the maximum dose of 40 mg per m2 body weight
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the post marketing setting in patients taking roactemnra : very common side effects ( may affect more than 1 in 10 people ) allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , which may travel through the mouth and skin blisters and stomach ache signs and symptoms of liver toxicity . rare side effects these may affect up to 1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 mg . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg ). each 20 ml vray contains 400 mg of the active substances of tocelizumb ( 20mg ). the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the pack roactrem
what onbrez breezhaler is onbrezer contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . what onbreez breez inhaler is used for onbrezy breezcheler is prescribed to help breathe easier and reduce breathing difficulties caused by a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles relax , making breathing difficult . this medicine works by relaxing these muscles in your lungs , making it easier for air to get in and out of
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using onbrezer breezer : - if there are any signs of heart problems such as epilepsy , thyroid gland problems , thyrotoxicosis ( diabetes ). your doctor may decide to reduce the dose or stop treatment with on brez breezer . tell
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day ( one 300 microgram ) twice a week . your doctor will tell you how many capsules to use . your dose may be adjusted depending on how you respond to the treatment . you should use your inhaler at least 24 hours after you last used it . onbrez breezhaler is supplied as an inhaler and capsules ( in blisters ) containing the medicine are supplied in inhalation powder . the onbreez breez inhaler
what onbrez breezhaler contains - each onbrex breez inhaler 150 mg capsule contains 150 mg indacaterol . - the other ingredients are indacatersol maleate , lactose and the capsule contains gelatin . - eachonbrez bronzhalER 300 mg capsule containing 300 mg indiacaterol , indacatesol maleates , lactos and the capsules contains gelatin , which is contained in an inhaler . capsules are provided in blisters . the capsules contain a white powder . - onbreez breezeler 150mg capsule contains 300 mg of indacate . -
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events (
do not take clopidogrel hcs - if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - if there is severe liver disease . if you think any of these apply to you , or if you have any further questions on the use of clopridogrel clcs , ask your doctor or pharmacist . warnings and precautions take special care with clopIDogrel ccs if any
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopipidogel ( as hydrochloride ). the other ingredients are ( see section 2 ' clopide hcs contain hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , tal
feciderocol is an antibiotic medicine that belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that are resistant to other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). if this happens , tell your doctor straight away . if you experience severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , tell the doctor
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it usually takes about 3 to 2 weeks . your doctor will decide how long fetcroja treatment will last . your dose will be decided by your doctor . this is to check that you are getting the best results and to reduce the risk of infection . your infection will be treated as soon as possible if you get any pain . the fetcroja infusion will be given into a separate vein . if you have kidney problems tell your doctor if you suffer from kidney problems . if your doctor decides that you need to be treated
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction ( sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions with difficulty swallowing or breathing ). this reaction may be life - threatening . diarrhoea , stools , blood or mucus may occur during treatment with medicines that slow bowel movement . tell your healthcare professional straight away . other side effects include : very common side effects ( may affect more than 1 in
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefingerocol . - the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojade is a white to off - white powder for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat adults with lymphomatous meningitis . lymphomatinous meneningitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte is a type of protein that recognises and attaches to lymphoma tumour cell cells .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking depocyte and contact your doctor immediately . taking any dexamethasone tablets may increase the risk of unwanted effects . if your side effects are not well controlled , or if you
before starting treatment with depocyte , your doctor will decide on the type of cancer to be treated . depocyte is prepared by injection in a lumber sac . depocytes is given to you by your doctor or nurse . the recommended dose , which is based on the body surface area , is 1 mg / kg of body surface surface area ( i . e . 5 cm² ) of depocyte . dexamethasone is given as 5 mg / ml of solution . each depocyte dose will be diluted to reduce any side effects . the amount of depocytes that is given depends on the temperature ( i. e . 22 to
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects may occur during or after your treatment . the following side effects have been reported with depocyte : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very common : affects 1 or 10 users out of 10 not known ( frequency cannot be estimated from the available data ) very rare ( affects less than 1 users in 10 , 000 ): very rare : affects lessthan 1 user out of 100 not known : frequency cannot estimate from the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . after reconstitution , depocyte must be used within 4 hours . do this if the solution is discoloured or if there is a changed appearance or if the liquid is discoured or contains particles . depocytes must be mixed with cytarabine
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cytarabiline . one vial of 5 ml solution contains 50 mg cytabine ( as besilate ). - the other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoylophosphatidoylglycerol , sodium chloride , water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . depocyte 5 ml is supplied as a single injection . it is available in packs containing
what bemrist breezhaler is bemist breez inhaler contains two active substances called indacaterol and mometasone furoate . indacterol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone furyate belongs to an important group of medicine called corticosteroids . corticoplastics are used to reduce the swelling and irritation ( inflammation ) in the smaller airways , which can lead to breathing
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before using bemist breez inhaler . - if your doctor thinks you may be allergic . - tell your physician if you have heart problems , such as an irregular or fast heartbeat . - you have thyroid gland problems . - have diabetes , high blood sugar , seizures or low level of potassium in your blood . - suffer from severe liver problems . tell
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . you should use the medicine every day , at the same time of the day . do not change the dose unless your doctor tells you to . do this to help control your asthma or your symptoms . be sure to use bemist breez inhaler every day . how bemrid breezhilder is used bemrim breezhler comes as an inhaler and capsules . the medicine is inhaled through the
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other sideeffects include the following listed below : very commonly ( may affects more than one in 10 users ): sore
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled in a single inhalation each contains 173 microgram indacate . each 150 microgram inhalation contains 150 microram indacatesol and 80 microgram mometsone furyate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 125 microram of indacatedol and 62 . 0 microgram of momet
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events ( such as stroke , heart attack , or death ).
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking zylltt . warnings and precautions talk to your doctor or pharmacist before taking the zylltic tablet if you : have a risk of bleeding such a medicalcondition that puts you at risk of internal bleeding ( such as - a stomach obcer ) -
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are lactose ( see section 2 under ' zyllts contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what zyllT looks like
lamivudine teva contains the active substance lamivudin . lamivuda teva is used to treat long term ( chronic ) hepatitis b infection in adults . lamibudineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage ). lamivodine teeva works by reducing the amount of hepatitis b in your body . this results in a reduction in liver
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamividine tevas is used in combination with other similar medicines . it may increase the risk of serious side effects , especially if you have liver disease such as hepatitis c . if you become overweight , your doctor may need to change your dose . you will have blood tests periodically during treatment with your medication ( see section 4 " warnings and risks "). if you take more lamivUDine teeva than you should if you think you may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you take it every day , as long as your infection is getting better . it does not matter whether you are taking it every morning or evening , as your illness will get better over time . your dose of lamivuda teva should be taken once a day . if you take more lamivuxine tevas than you should if you have taken more lamvudine than you have been told
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects of lamivudine teva are related to other conditions linked to hepatitis b . the following side effects have been reported during therapy for ' hepatitis b ' in adults . the side effects reported during lamivudaine clinical trials were : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea , and increases in liver enzymes . these are signs that the liver is not working properly . these may be due to the build - up of enzymes in the muscles .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be used immediately after dilution . do this if you notice that the solution is not clear or contains particles . do ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivuda . each film - coated tablet contains 100 mg of lamivu . - the other ingredients are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivUDine teeva looks like and contents of the pack orange , biconvex film - - coated tablets , debossed with
nespo ( an anti - anaemic ) helps control your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . nespo works by blocking the effect of the natural hormone erythropoietin . erythroietin works by helping your kidneys and your bone marrow produce more red bloodcells . it is also used to reduce the production of darbepoetin alfa . chronic renal failure ( symptomatic anaemia ) chronic renal fail is caused by kidney failure . kidney failure occurs when the kidney does not produce
do not use nespo if you have high blood pressure or are taking other medicines . if you are allergic to nesco ( darbepoetin alfa ) or r - huepo ( used to treat high bloodpressure ). if you take medicines to treat sickle cell anaemia ( e . g . epileptic fits ( seizures ), convulsions or seizures ). if your doctor has told you that you have liver disease . if any of the above applies to you , do not use neespo and talk to your doctor . warnings and precautions talk to you doctor before using nespos if you suffer
your doctor will carry out blood tests before you start nespo to check your haemoglobin level . the usual starting dose is 10 mg . your doctor will then increase your dose to a haemogl level of 10 mg every 12 hours using the pre - filled syringe . this is given into a vein ( intravenous ). if you have chronic renal failure , your doctor may give you a single injection under the skin or into a veins ( intravenously ). how much nespos you will receive your doctor or nurse will check your anaemia regularly . the dose of nespa given will depend on your body weight . the
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : 471 common ( may affect up to 10 in 100 people ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 , 000 people ): blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare ( may affects up to1 in 10 , 000 users ): serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the outer carton in order to protect from light . after first opening , use within 30 days . after this , use in children and adolescents no longer than 7 months of age . do this by referring to the new expiry dates which are printed on the label and carton . do away with n
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . the active substances darbiepoetein ala are produced by recombinant darp technology . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e487 ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and contents of the pack n
macugen is a solution for the eye called pegaptanib . this medicine works by stopping abnormal formation of new blood vessels in the eye . macugen is used for the treatment of adults with macular degeneration . in this disease , vision loss occurs due to damage to a part of the retina called the macula . the macular is the thin layer between the eye and the eye ( amd ). abnormal blood vessels grow in the retina and the macul . these new blood structures bleed and leak fluid causing the maculas to bulge , distorting or destroying central vision . this can lead to vision loss . if you have
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in the eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you have or have had an infection or bleeding in theeye , stop using macug injection and contact your doctor immediately . if any of these apply to you , tell your doctor straight away . if the following symptoms occur , contact your eye doctor immediately : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased
mugen will be given to you by a doctor or nurse . injections of macugen will usually be given by a single injection into your eye . the recommended dose is 6 to 9 ml . the injection will be injected into the vitreous part of the eye ( the front part of your eye ). macugen is given in combination with antibiotic eye drops . your doctor will clean your eye and give you some local anaesthetic ( numbing medicine ) to prevent any pain you may have after the injection . if you are allergic to antibiotic eyedrops , you should not receive antibiotic treatment for eye infection . macugen volume is injected into your
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 under " warnings and precautions " and in section 4 . if you experience any of these symptoms ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection is a single dose pack supplied in a pouch . each pack contains a pre - packed syringe of 0
what kepivance is kepvelance contains the active substance palifermin . it is produced by biotechnology in the laboratory of escherichia coli . palifermine works by stopping the growth of epithelial cells in the mouth and digestive tract and by blocking their growth in the tissues below the skin . what kepivalance is used for kepervance is prescribed to treat oral mucositis ( soreness , dryness or inflammation of the mouth ) as a side effect of treatments for your blood cancer . if your bloodcancer is not well controlled with chemotherapy , radiotherapy or autologoushematop
do not use kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children under 18 years of age . other medicines and kepipivance tell your doctor or pharmacist if you have recently taken or might take any other medicines . kepivalance may be taken with heparin . if you recently taken heparrin , tell your physician . pregnancy and breast - feeding kepvelance is not recommended if you plan to become pregnant . if pregnant ,
how kepivance is given your doctor will decide how much kepivanance you will receive . your doctor or nurse will decide the dose you will need . the usual dose for cancer treatment is one 60 mg tablet of kepvelance per kilogram body weight , given as an intravenous injection ( into a vein ). how kepivalance is administered kepiper will be given to you three days before chemotherapy ( chemotherapy and radiotherapy ) in a hospital . it is given at least three days after chemotherapy and at least four days after radiotherapy . the chemotherapy will be stopped at least two days after the chemotherapy has
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include skin rash , itching , redness , pruritus ( erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , decrease in lipase and amylase levels , and increase in levels of digestive enzymes in the blood . not known ( frequency cannot be
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder supplied in a glass vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitepine which increases the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinaconalcate accordphima is used : to treat secondary hyperparathyroidism in adults with serious kidney disease who are not on dialysis or who are unable to eliminate waste products that increase the level of calcium in the bloodstream ( hypercalcaemia ). to treat parathy thyroid
do not take cinacalcet accordpharma if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). if you have low levels of calcium in your blood . if your blood calcium levels are too low . warnings and precautions talk to your doctor or pharmacist before taking cinocalcut accordpha . if you think any of these apply to you , or if you were not sure , talk to the doctor or nurse before taking this medicine . if any of those apply to your , tell your doctor straight away . seizures ( fits or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . you should take cinocalcate accordphsi at the same time each day . the tablets should be swallowed whole with water . your doctor will take regular blood samples during treatment to monitor your progress . if you have secondary hyperparathyroidism , your doctor may prescribe cinaconalcite accordphara alone or with a lower dose . the usual
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches or cramps , seizures ( these may be signs that your calcium levels are too low ). hypocalcaemia ( swelling of the face , lips , mouth , tongue or throat , which may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in every
what cinacalcet accordpharma contains - the active substance is cinacealcep . each film - coated tablet contains 30 mg , 60 mg or 90 mg cinaconalcip ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcel accordpharmaceutical looks like and contents of the pack ciniac
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformatin belongs to the class of substances called biguanides . they work together to reduce blood sugar levels in adult patients with diabetes called ' type 2 diabetes mellitus '. this medicine works by reducing the amount of insulin produced by the body . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas or empagliflo
do not take jentadueto - if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severely reduced kidney function . - if any of these apply to you , tell your doctor before taking jentadoueto . warnings and precautions talk to your doctor or pharmacist before taking this medicine : - if : you have severe reduced kidneyfunction - if this is the case - if the level of sugar in your blood is too low - if there is a risk of lactic acidosis (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jentadueto should be taken with or without food . if you currently take metformin or individual tablets of linagliptin or metformine , take this dose as soon as you remember . if this medicine is not suitable for you , take it at the same time each day . if an upset stomach occurs , take the dose as recommended . the recommended dose is one 5 mg linaglptin tablet once a day with food . the dose may be increased to one 2 , 000 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change , confusion . hypoglycemia is a very rare ( may affect up to 1 in 10 , 000 people ) but very serious side effect . jentodueto plus sulphonylurea may interfere with the normal working of the combination jentadenu
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . blister : store in the original package in order to protect from light . do this medicine if you notice any visible signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformine hydrochloric acid . - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol . what jentudueto looks like and contents of the pack jent
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older . it belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants works by reducing the amount of hla - b * 5701 in the body . it is used in combination with hiv medications in adults and adolescents aged 12 and older who are infected with hla b * 5401 . your doctor will discuss with you whether edur
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent if you : are taking any of any of : the following medicines : carbamazepine , oxcarbazepine ( e . g . phenobarbital ), phenytoin ( medicines used to treat epilepsy and prevent seizures ) rifampicin and rifapentine ( medicines to treat some bacterial infections such as tuberculosis ) omeprazole , esomepraz
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( 18 years of age and older ) the recommended dose of edurant is one tablet once a day . do not take more than one tablet a day with food . do this if you have the impression that the effect of eduria is too strong or too weak . rifabutin is a medicine used to treat some bacterial infections . if you take more edurent than you should if you accidentally take more rifibutin than you were told to , talk to your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream ( triglycerides , lipase , bilirub
what edurant contains the active substance is rilpivirine . each tablet contains rilpalpivira hydrochloride . each film - coated tablet contains 50 mg of ril pivirrine . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . tablet coating : lactate monohydrate ( see section 2 ), hypromellose 2910 ( e464 ), talc ( e553b ), titanium dioxide ( e
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . type 2abetes develops if your body does not make enough insulin to control blood sugar levels . insulin is a substance that your body makes . rosigllitazon and met formin work together to make the insulin that your bodies make . this helps your body to increase the level of sugar in your blood . avandamvet is also used in combination with a sulphonylurea ( another type of diabetes medicine ) to treat high blood sugar .
follow all the doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor or pharmacist if you are not sure . your doctor may need to change your dose of avandamet . if you : - are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avANDamet ( listed in section 6 ) - have had a heart attack - have severe angina - have heart failure - have experienced heart failure in the past - have suffered severe breathing difficulties - have liver disease - have diabetic keto
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is taken once a day in the morning and once a morning in the evening . the dose is 1 tablet in the mornings and 8 tablets in the afternoon . the maximum dose is 4 mg rosciglitrazone (ivalent to 1000mg metforman ). thisdose is taken twice a day . your doctor will tell you how many tablets to take .
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet can include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and seek medical advice straight away . lactic acidosis ( lacticacid is a build - up of acid in the blood ( lactacidosis is a common side effect in patients taking metformin ) and severe kidney disease ). symptoms of lactic ache
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the exp expiry dates refers to the last day of that month . this medicinal product does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do away with the blister or the blister without talking to your pharmacist .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosigllitazon ( 500 mg metforma ), 2 mg rossiglitasone ( 500mg metforman ), 2mg rosIGlitazione ( 1000 mg met formin ), 4 mg roshiglitrazone ( 1000mg met formformin ). the other ingredients are sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate , povidone
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelmylan is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke , heart attack , or death ). you
do not take clopidogrel mylan 31 if you are allergic to clopidineogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrel melan . warnings and precautions talk to your doctor or pharmacist before takingclopidoggingrel myl : if you think you may be at an increased risk of bleeding such a medicalcondition that puts
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopiprel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 " clopiderel myl contains hydrogenatedcastor oil "), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 . what
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ), which may be fatal in some cases . it is used in a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets in the blood . platelets are blood cells that help the blood to clot and stop bleeding .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). if you have a history of blood clots in the veins or arteries . if you think blood cl clots may be a sign of cancer . if your doctor has switched you from the contraceptive birth control pill to hormone replacement therapy . if recently had surgery or if you get injured . warnings and precautions 23 if you : are overweight or have advanced chronic liver disease . children and adolescents do not give this medicine to children or adolescents below the age of 18 years . this medicine is
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to one 8 mg tablet twice a day depending on your response to doptelet . your dose may be adjusted by your doctor . the maximum recommended dose of doptelets is 20 mg , 40 mg , 60 mg or 5 mg per day depending upon your platelet counts . if you take more dopteol than you should if you accidentally take too many tablets , contact your doctor immediately . if possible
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches and fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormboprag maleate equivalent to 20 mg avatrambopg . - the other ingredients are lactose monohydrate ( see section 2 ), microcrystalline cellulose , crospovidone type b [ e ], silica , colloidal anhydrous , magnesium stearate . - film - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what dopteel looks like and contents of
rapiscan belongs to a group of medicines called ' coronary vasodilators '. these are used to monitor the heart arteries , to measure heart rate and to relax the muscles in the heart . rapiscan is used for the following types of heart scan : ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken using a machine to measure the muscles of the heart using a readmill . a scan contains only a small amount of radiopharma . it is injected into your body through a vein ( usually by your hand ). images are then taken
do not use rapiscan if you have slow heart rate , high degree heart block , sinus node disease or a pacemaker that does not work properly , chest pain ( unstable angina ) or if you are not sure , talk to your doctor before starting treatment if you suffer from low blood pressure ( hypotension ) or heart failure if you think you may be allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to a doctor or pharmacist before using rapiscen if any of these apply to you : if you : have a recent serious heart
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) in a maximum of 400 ml . the recommended dose is a 5 ml solution the injection will be administered once a week for a total of 10 days . the dose may be adjusted depending on your weight and your general condition . an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution should be given once a day for a maximum period of 5 days . if you are given more rapiscan than you should if you have been
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects usually occur within a few days of the rapiscin injection and usually disappear within 30 days after receiving any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be due to damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , ministrokes , weakness of the face and inability to speak . rapiscen may cause a stroke ( cerebrovascular accident ) or
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction ( impotence ), a condition where a man cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has prescribed medicines containing nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain ") in adults . if you have not been prescribed any of these medicines , please contact your doctor . - if the doctor has recommended nitric oxide donors such as amyl nitrite , which may lead to an increase in your risk of a dangerous drop in yourblood pressure . -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once a day . viagra film - coated tablets are for oral use . viaga orodispersible tablets are also for oral administration . swallow the tablets whole with a glass of water . do not crush or chew the tablets . viag can be taken with or without food . taking viagra with food will help you to get an erection . if you feel sexually stimulated , you should continue taking viaga until your doctor tells you otherwise . if your sexual desire does not
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . if any of the side side effects gets serious , stop taking viagra and seek medical help straight away . an allergic reaction is uncommon ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . if you get chest pains , you may be in a semi - sitting position and you may need to take nitrates to relieve your chest pain . prolonged and sometimes painful erect
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are marked with "
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to : : treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa . treat parkinson ', s disease is thought to be responsible for the symptoms in adults with moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sifol : - if your doctor has told you that you have any medical conditions that could be associated with symptoms of kidney disease . - if any of these apply to you , tell your doctor straight away . - hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are temporary . - dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets taken once a day . during the first week , 1 tablet of sufrol 0 . 088 mg / 0 . 264 mg tablets will be taken once daily . after 1 week , 2 tablets of sofrol 0. 088mg / 0. 264 mg may be taken if your symptoms return but do not stop taking tablets without first consulting your doctor . the usual starting dose is 1 tablet once a morning . after 2
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( might affect up to 1 in 100 people ) rare ( may affects up to1 in 1 , 000 people ) very rare ( might affects up in 1 in10 , 000 patients ) not known ( frequency cannot be estimated from the available data ) - if you have parkinson ' s disease , tell your doctor straight away if you notice any of the following side effects : - dyskinesia ( abnormal , uncontrolled movements
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg of pramipxole as 0 . 125 mg , either 0 . 25 mg or 0. 5 mg of 1 mg pramiperxole dihydrochloride monohydrate . the other ingredients are mannitol , maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what sifroll looks like and contents of the pack sifol 0 . 019 mg tablets are white to
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used to prevent allergic conditions from occurring in the eye , and to reduce the allergic reaction . allergic conjustivitis may occur when you are exposed to some materials ( allergens ) that may cause allergic reactions such as itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . do not try to cover up any of the effects you may feel worse .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using emadin : - if the medicine contains benzalkonium chloride . emadino contains benzaldehyde . see section 6 . clinical trials should be performed before and during treatment with emadined . - if patients with kidney or liver problems are treated with emademine . other medicines and emadines tell your doctor if you use , have recently used or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use one drop twice a day ( morning and evening ). use in children and adolescents use in adults and adolescents 3 months to less than 18 years of age . use in infants and children 1 year to less 18 years old use in adolescents 2 years to less less than 1 year of age use in adult use . do not use this product if you have any other questions . how to use the emadine bottle : wash your hands before using it . the bottle can be opened and the
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops can cause them . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects : ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneel staining and dry eye . general side effects include headache , difficulty sleeping , sinus headache , bad taste and rash . generalside effects
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadarine is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetir acetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). leveiracetamine is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). leetiracetamer has been
do not take levetiracetam actavis - if you are allergic to leveturacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking levetiraacetamactavis - tell your doctor if you have kidney problems . - tell the doctor if any slow down in the growth or unexpected puberty development of your child has been reported . - if your child is taking anti - epileptics ( see section " other medicines and levetiaracetam "). - tell a doctor if your son
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents from 16 years of age and older : the usual dose is 1 , 000 mg once a day . your doctor may increase your dose to 3 , 000 iu once a week depending on how you respond to levetiraacetamactavis . your daily dose will be gradually increased to 2 , 000 to 1 , 500 iu per day . after therapy
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest hospital emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms , a rash on the face with an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and a decrease in a type of white blood cell 56 ( eosinoph
what levetiracetam actavis contains the active substance is levetiraacetam . levetaracetamactavis 250 mg : each film - coated tablet contains 250 mg of levetoracetam ( as levetilacetam ). levetieracetam actingavis 500 mg : one film - coating contains 500 mg of the active ingredient leveturacetam , as levantiracetamine actavis 750 mg : two film - coat contains 750 mg of of leveriraceta ( as velvetir acetam ). what levetiaracetam effectavis looks like and contents of the pack
ceremellipta contains the active substance umeclidinium bromide which belongs to a group of medicines called bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become damaged and difficult to use . this can lead to breathing difficulties . difficulties in breathing can also result in tightening of the muscles around the airway . this medicine blocks the tightening of these muscles in the air passages , making it easier for air to get in and out of the lungs . this
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . incruruse ellipta should not be used in patients with asthma . if you suffer from heart problems . if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). if you know that you suffer severe liver problems . immediate breathing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use incruse ellipta every day . if you use more incruce ellipta than you should if you have used more inculse elliptas than you have been told to , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs , you may need to use
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination . these may be signs of a urinary tract infection . common cold infection of nose , throat cough feeling of pressure , pain in the cheeks and forehead . these could be signs for inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the tray , the inhalard should be used within 6 months . once the tray has been opened , the active substance of the medicine should be transferred to the inhaluer and used within 30 . once removed from the sealed
what incruse ellipta contains - the active substance is umeclidinium bromide . each single inhalation provides a delivered dose of 55 micrograms umeklidinia to a maximum of 65 microgramms umecylidinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrute ellipta is an inhalation powder . the ellipta inhaler consists of a grey plastic body , a
nucala contains the active substance mepolizumab , a monoclonal antibody . this is a type of protein that recognises and attaches to specific proteins in the body . it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type white blood cell that helps the airways to open ) and affects the lungs . eosynophilic asthma is the most common form of asthma in people with asthma . nucala is used in adults to prevent asthma attacks and to reduce the need for medicines called high dose inhalers
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to treat your asthma with nucal . if your asthma does not respond to nucalan treatment , your physician may decide that you are not allergic to other types of injection site reactions medicines of this type ( monoclonal antibodies ) may cause severe allergic reactions to other parts of your body ( see section
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week for 1 week . the pre - filled pen may be used for up to four weeks . your doctor will decide how long you should receive nucala . duration of treatment with nucal your doctor may decide to continue the treatment with a lower dose . if you use more nucalo than you should if you have used more nuala than you have been told to , tell your doctor or nurse immediately . if your asthma symptoms get worse or if attacks
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms can be severe . symptoms can include chest tightness , cough , difficulty breathing fainting , dizziness or feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar reaction to nucal . other side effects include :
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre filled pen in the outer carton in order to protect from light . after first opening , use within 7 days . do away with the pre pre - fill pen if you notice it is damaged or shows signs of tampering . do discard the pre / filled pen if it has not been used within 7 weeks .
what nucala contains - the active substance is mepolizumab . each 1 ml vial contains 100 mg of mepolixumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucale is supplied as a pack containing 1 vial or as a multipack containing 3 vials of 1 vials . not all pack sizes may be marketed .
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib works by stopping cell survival and slowing down the number of myelomas cells . it also works by blocking the action of a lot of proteins called proteasomes . what ninlalo is used in adults and children with multiple myelooma , ninlero is used either alone or in combination with lenalidomide or dexam
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you : if you have been treated with ninlallo before , if you experience bleeding , if your doctor has told you that you have persistent nausea , vomiting , diarrhoea , if any you have nerve problems , such as tingling , numbness , swelling or a persistent rash . if you suffer from liver or kidney problems , your doctor may decide to reduce the
instructions for use and use of ninlaro must be given to you by a doctor experienced in the treatment of multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of ninlio is lenalidomide ( a medicine that works by blocking the action of dexamethasone ), an anti - inflammatory medicine . how to take ninllio take lenalidome and dexamETHasone once daily for the first 3 weeks of the 4 - week treatment . lenalidomonide 25
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash that may become itchy all over the body rare side effects these may affect up to 1 in 1 , 000 people : severe skin rashes , red to purple bumps (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store below 30 . store in the original package in order to protect from moisture . once the capsule has been opened , use this medicinal product immediately . do do not take this medicine if you notice any damage or signs of tampering to the pack . do away with any unused medicine packaging . do this as soon as possible after opening . do throw away any medicines via wastewater or household waste . ask your pharm
what ninlaro contains the active substance in each capsule of ninlar 2 . 3 mg hard capsule is ixazomib . each capsule contains 2 .3 mg ixasomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide and black iron oxide . the printing ink contains : - the capsule content contains : ixar 3 mg ileazomab 4 . 3mg ixa
do not use palforzia if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor or pharmacist before using palfORzia . children and adolescents this medicine is for use in children and young people ( aged 4 to 17 years ) who are not yet fully immunised against peanut allergy . the active substance in the medicine is peanut ( desensitisation ). palfiorzia does not cause allergic reactions . palforszia is not used to treat food allergies . if you have any further questions on the use of this product , ask your doctor ,
do not take palforzia if you are allergic to peanut or soya or any of the other ingredients of palfourzia ( listed in section 6 ). if your asthma is not well controlled with food , you have a problem swallowing , you suffer from long term problems with your digestive system , you are suffering from a severe mast cell disorder , you experience severe or life - threatening anaphylaxis within 60 days of starting treatment . if this applies to you , tell your doctor . warnings and precautions talk to your doctor before taking palfurzia . the symptoms of peanut allergy may occur during treatment with p
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the doctor will determine the dose you need and will determine if you need to take a smaller dose . allergy if you have allergic reactions ( anaphylaxis ), your doctor may decide to reduce your dose to a single dose of 3 mg once a day . treatment with palforzia will be initiated by your doctor . initial doseescalation is the first step in the initiation of these treatment steps . the initial dose elevation and up - dosing steps should be repeated every three weeks . if you take
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions - if you have any of the following symptoms while taking palfORzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing or speaking - changes in voice , dizziness or fainting severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin palforsia may cause problems with the stomach and digestive system ( eosinoph
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or particles in the vials . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palforbir . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg oral powder in capsules with opening microcrycrystallrine cellulose ( e460 ), colloidal Anhydroussilica and and magnesium unstearate ppalforzeria 300 mg oralpowder in sachet microcrystine celluloses ( e463 ), colloid anhydrated silica , and magnesium
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions . zerene is used to treat sleeping problems in adults . it is used during treatment . it should be used only if you have problems sleeping .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes very weak and tired muscles , severe breathing and chest problems ). children and adolescents do not give this medicine to children and adolescent under 18 years of age because it has not been studied in this age group . other medicines and zeren tell your doctor or pharmacist if you take , have recently
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one capsule of 10 mg . if you have difficulty falling asleep , you should take the capsule with you . if your doctor tells you to stop taking zeren , you may need to take the capsules at least one hour before or one hour after your last meal . if the dose is 65 mg or higher , you can take the dose as soon as you remember . if mild to moderate liver problems are not treated , you could take the 5 mg dose at the same time . do
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common : may affect more than 1 in 10 people common : might affect up to 1 in10 people uncommon : may affects up to1 in 100 people rare : may affecting up to one in 10 , 000 people very rare : might affects up in 1 in 1 , 000 children very rare ( may affect up in 10, 000 people ) very rare cases : may not affect up of 1 in
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( i171 ). - the printing ink contains gelatin , titanium dioxide , red iron oxide ( e172 ), yellow iron oxide , black iron oxide (< e172 ) and sodium laurel sulphates ( e133 ), silicon dioxide , ( s - 13050 ). - printing ink containing shellac
